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ABSTRACT OF THE DISSERTATION 
 
Elucidating the mechanism of synergy 
in actin assembly by Spire and Cappuccino 
 
by 
 
Alexander Odysseus Bradley 
Doctor of Philosophy in Biochemistry, Molecular and Structural Biology 
University of California, Los Angeles, 2019 
Professor Margot E. Quinlan, Chair 
 
 
Two actin nucleators, Spire and Cappuccino, collaborate to build a network of actin filaments 
that connect vesicles and the cortex in the fruit fly oocyte. This actin mesh is built by a 
conserved mechanism and by homologous proteins (Spire-1/2 and Fmn-2) in mouse oocytes. In 
each animal, proper regulation of mesh is necessary to establish cell polarity. A direct 
interaction between Spire and Cappuccino is required to regulate the actin mesh and for in vitro 
synergistic actin assembly; however, we understand little about why the interaction is 
necessary. To mimic the geometry of Spire and Cappuccino in vivo, Spire was immobilized on 
beads and observed by TIRF microscopy. These experiments revealed that increased 
nucleation is a major part of synergy with Cappuccino and that Spire alone binds both barbed- 
and pointed-ends of actin filaments. We identified Spire’s barbed-end binding domain (WH2-A) 
and observed partial rescue of fertility by a loss-of-function mutant, indicating that barbed-end 
binding is not necessary for Spire’s in vivo function, but that it may play a role under normal 
circumstances. 
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In addition, we found that Spire’s four WH2 domains variably participate in nucleation and other 
functions (e.g. sequestration) and that mutants of each WH2 domain can be modularly 
combined to tune Spire activities. We also identified new value in an existing, nucleation-
incompetent Cappuccino mutant as a tool to reciprocally explore its own contributions to 
synergy with Spire. We found that this mutant does not nucleate actin but processively protects 
barbed ends from capping protein, and allows – but does not accelerate – the elongation of 
filaments in the presence of profilin. Furthermore, preliminary data suggest that this mutant 
synergizes with Spire – both in pyrene assembly assays and on beads – through a mechanism 
other than the dimerization of Spire. Finally, we demonstrate that Spire’s amino acids 490-520 – 
recently identified as containing a MyoV binding site – have an inhibitory effect on nucleation by 
Spire, resolving some discrepancies in reported actin assembly rates. 
 
Taken together, these insights emphasize the complexity of Spire—Cappuccino synergy, mesh 
production, and regulation of polarity in the fruit fly oocyte. Our improved understanding of the 
components of synergy studied herein should permit the development of a more sophisticated, 
biomimetic mesh assembly system, and a more precise interrogation of actin assembly activities 
by Spire and Cappuccino. 
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Chapter 1: Introduction 
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The actin cytoskeleton 
Actin is a ubiquitous protein and an essential component of cellular cytoskeletons. Actin serves 
critical roles in a cell’s division, exploration of its environment, morphology, motility, vesicle 
trafficking, and more. The highly conserved, globular actin (G-actin) monomer (≥ 93% sequence 
identity between all human isoforms (Perrin and Ervasti 2010)) must polymerize into dynamic 
filaments (F-actin) to accomplish these functions. These filaments scaffold structures to resist 
forces and provide structural rigidity; grow and push other structures, like membranes; and 
operate as molecular highways along which motor proteins travel and transport various cargoes. 
 
Despite serving in such essential and varied roles, actin’s ability to form filaments and 
accomplish these dynamic tasks is hindered from the onset, due to the kinetically disfavored 
nucleation step (Pollard 1986; Pollard and Cooper 1986). This initial, spontaneous assembly of 
actin filaments occurs slowly due to the instability of actin dimers. Actin trimers or tetramers 
(nuclei) are stable enough to template the growth of a filament but the kinetic hurdles of the 
species preceding this complex prohibit the spatiotemporal precision required for actin’s various, 
dynamic roles in the cell. 
 
There are myriad actin-binding proteins (ABP’s) which even further discourage actin 
polymerization. ABP’s which sever and halt the growth of filaments (e.g. ADF/cofilin and 
capping protein, respectively (Edwards et al. 2014; Maciver and Hussey 2002)) or bind and 
sequester G-actin (e.g. profilin and β-thymosin (Huff et al. 2001; Theriot and Mitchison 1993)) 
further disfavor the assembly of various actin structures. However, within the entourage of 
known ABP’s lies an astonishing diversity of regulation, including three protein classes which 
accelerate the rate of elongation and/or nucleation of filaments: Arp2/3 complex, formins, and 
tandem actin-binding domain proteins (Fig. 1-1) (Goode and Eck 2007). Members of these ABP 
families are typically observed to assemble structures with distinct morphologies and functions. 
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However, two ABP’s of particular interest – Cappuccino (Capu, a formin) and Spire (Spir, a 
tandem actin-binding domain protein) – have been demonstrated to collaborate to build a single 
structure: the actin mesh. 
 
 
Figure 1-1 – Comparison of the mechanisms by which formins, the Arp2/3 complex, and 
Spire nucleate actin polymerization 
 
From Goode & Eck (2007). (From top) Spontaneous actin assembly. Actin dimers and trimers are unstable and 
rapidly dissociate. Formins (green dimer) stabilize intermediate structures, like the actin dimer. The Arp2/3 complex 
(multi-colored) is thought to mimic an actin trimer, forming a branch off of an existing filament. Spire (purple WH2 
domains) binds and organizes up to four actin monomers into stable, rod-like complexes. 
 
Formins and Cappuccino 
Capu and other formins assemble into donut-shaped homodimers which can bind and nucleate 
actin (Xu et al. 2004). Their formin homology 2 (FH2) domain is required for dimerization and 
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nucleation, via stabilization of the kinetically disfavored actin homo-dimers and –trimers. Once a 
filament has been nucleated, it can elongate at either end, but each end interacts with a 
different complement of proteins and grows at a different rate. The slower growing of these is 
called the pointed end, while the barbed end elongates ~10-fold faster (Pollard 1986). 
Like other proteins in the formin family, Capu can processively track and enhance the 
elongation of the already faster-growing, barbed end of an actin filament (Paul and Pollard 
2009). Capu acquires G-actin to accomplish this function by binding the aforementioned, 
ubiquitous ABP, profilin. With nearly all G-actin predicted to be profilin-bound in the typical cell, 
the two proline-rich, profilin-binding FH1 (formin homology 1) domains of the Capu homodimer 
are aptly suited to rapidly acquire and add actin monomers to a filament (Courtemanche and 
Pollard 2012). 
 
Capu accelerates the polymerization of actin filaments ~6-fold (to ~35 actin subunits/s), utilizing 
profilin-actin (PA) (Vizcarra, Bor, and Quinlan 2014). Its processivity permits Capu to accelerate 
the addition of over 300,000 PA subunits in this manner before falling off of a filament; all the 
while, protecting the barbed end from becoming bound by other ubiquitous ABP’s like capping 
protein, which can arrest its growth (Bor et al. 2012; Vizcarra et al. 2011). The combination of 
these activities typically results in the production of long bundles of filaments by formins. 
However, to build mesh, Capu collaborates with another nucleator: Spir. 
 
WH2-domains and Spire 
Another common class of actin nucleator contains tandem, actin-binding domains. The most 
common of these domains is the Wiskott-Aldrich syndrome protein (WASp) homology 2 (WH2) 
domain. The WH2 is a ubiquitous, ~20 amino acid-long domain found in activators of the Arp2/3 
complex (e.g. N-WASp, WAVE2) and in formins (e.g. INF2, mDia1), in addition to proteins 
containing tandem stretches of WH2 domains (e.g. Spir, CobL, VopL, Sca2) (Dominguez 2016). 
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Spir is the founding member of the tandem WH2 domain-containing protein class. Identified by 
Dr. Quinlan in 2005 to be a novel, pointed-end nucleator of actin filaments, Spir contains four 
closely spaced, central WH2 domains (See Fig. 2-1A) (Quinlan et al. 2005). Electron 
microscopy (EM) data suggest that Spir binds a single actin monomer to each WH2 domain and 
arranges them into a rod-like shape (Quinlan et al. 2005). These Spir—actin rods may be 
structurally similar to the long-pitch of the two-start actin filament helix. However, it is unclear if 
this species templates the growth of a filament or if nucleation by Spir occurs by a different 
mechanism. 
 
Many tandem WH2 nucleators contain dimerization domains (e.g. VopL/F, Sca2) or can 
dimerize through interactions with other dimers (e.g. Cobl and BAR proteins) (Dominguez 
2016). Without such a domain or partner, a single Spir—actin rod structure, as seen by EM, 
may be better equipped for involvement in the polymerization-inhibiting functions of Spir (i.e. 
forming a so-called SA4 complex (Bosch et al. 2007)). In addition to its nucleation activity, Spir 
has been shown to sequester actin monomers and sever actin filaments and dimerization may 
be necessary for nucleation to prevail over these other activities. Indeed, when Spir is dimerized 
via fusion to VopL’s dimerization domain or GST, its nucleation activity is impressively 
augmented (Namgoong et al. 2011; Vizcarra et al. 2011; Vizcarra and Quinlan 2017). Therefore, 
an interaction with a dimeric protein such as Capu is likely to be favorable for actin assembly by 
Spir. In fact, genetic evidence of such an interaction was found as early as 1989. 
 
Ooplasmic streaming 
Shüpbach and Manseau identified the cappuccino and spire loci as essential for proper 
embryonic axial patterning (affecting the development of both the anterior/posterior and 
dorsal/ventral axes) in Drosophila melanogaster (Manseau and Schupbach 1989). Five years 
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later, they were implicated in the proper temporal control of ooplasmic streaming – a fascinating 
and still incompletely understood process by which the Drosophila oocyte mixes its contents in a 
concerted and rapid manner (Theurkauf 1994). The initiation of ooplasmic streaming requires 
precise regulation. Loss of function of either the cappuccino or spire gene results in the 
premature onset of this phenomenon and a catastrophic lack of polarity establishment in the fly 
embryo (Manseau and Schupbach 1989; Theurkauf 1994). 
 
Shüpbach and Manseau suggested that 
the phenotypes observed in mutant 
embryos might be due to defects in 
actin-based transport systems. 
Subsequent to these studies, an 
explosion of literature on actin 
nucleators, discussed above in brief, 
showed that formins are both nucleators 
and processive elongators of actin 
filaments, while Dr. Quinlan’s seminal 
work on Spir showed it to be a novel type 
of pointed end actin nucleator. These 
insights suggested a link between fast 
ooplasmic streaming and actin regulation 
by Spir/Capu. In fact, concomitant with 
the onset of fast streaming in Stage 10b 
and later oocytes, an actin mesh within 
the fly egg conspicuously disappears 
(Fig. 1-2A,B) (Dahlgaard et al. 2007). 
 
  
  A A’ 
B’ B 
C C’ 
Figure 1-2 – The actin mesh is prematurely absent 
in capu or spir-deficient oocytes 
 
Modified from Dahlgaard, et al. (2007). (A) The actin mesh is 
clearly present in a Stage 9 fly oocyte. (B) The actin mesh is 
absent in Stage 10b (shown), when fast streaming begins. (C) 
The mesh is prematurely absent in a capu-deficient, Stage 9 
oocyte. The result is the same for spir-deficient flies. (A’-C’) 
Images on right are blown up regions of the oocyte shown on 
the left. Scale bars = 30μm (gray) and 10μm (white).  
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Actin mesh 
A dense, interdigitated network of filaments, the actin mesh is a conserved structure found to 
serve roles in polarity establishment in multiple animals. In the fly, F-actin depolymerizing 
agents phenocopy capu and spir mutants (Manseau, Calley, and Phan 1996), which suggested 
that the process of fast streaming within the oocyte is temporally controlled by the Spir/Capu-
mediated mesh. In fact, it was subsequently shown that both Capu and Spir are necessary to 
build the mesh (Fig. 1-2C) (Dahlgaard et al. 2007). In the absence of mesh, premature fast 
streaming of fly ooplasm results in disturbed microtubule (MT) organization and the 
mislocalization of MT-dependent, essential polarity factors, such as bicoid, oskar, and nanos 
(Dahlgaard et al. 2007; Johnstone and Lasko 2001; Theurkauf 1994; Theurkauf et al. 1992). 
However, late onset of streaming is also detrimental. Oocytes with constitutively active Spir or 
Capu have denser meshes which disassemble too late in the egg’s development, thus delaying 
streaming and again interfering with proper polarity establishment (Bor, Bois, and Quinlan 2015; 
Dahlgaard et al. 2007; Quinlan 2013). 
 
While mesh is necessary for the regulation of streaming and the localization of mRNAs in the 
fly, analogous structures exist in plants and the oocytes of frogs, mice and starfish. In the eggs 
of mice and starfish, mesh is required for asymmetric positioning of the meiotic spindle and 
condensation of chromosomes, respectively (Azoury et al. 2008; Bun et al. 2018; Field and 
Lénárt 2011; Montaville et al. 2015). In fact, the mammalian homologues of Spir and Capu – 
Spir-1/2 and Fmn-2 – produce mesh in the mouse oocyte and in the absence of either, mesh is 
not created and the spindle fails to be properly positioned (Pfender et al. 2011). 
 
Spire and Cappuccino synergy 
The discovery that both Spir and Capu are actin nucleators led to the question of why both 
would be needed to build a single structure (Quinlan et al. 2005). This question is made even 
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more compelling by the observation that Fmn-2 and Spir-1 demonstrate a conserved function of 
regulating mesh and polarity within mammalian oocytes (Leader et al. 2002; Pfender et al. 
2011). 
 
We now know that a direct interaction between Spir and Capu is required for mesh assembly 
(Quinlan 2013). Work in the Quinlan lab showed that Capu’s C-terminal tail tightly binds (~100 
nM affinity) Spir’s conserved kinase noncatalytic C-lobe domain (KIND) (Bor et al. 2012). 
Binding of recombinant KIND domain inhibits Capu’s actin assembly. However; conversely, 
Capu-binding enhances actin assembly by Spir (Pechlivanis, Samol, and Kerkhoff 2009; 
Quinlan et al. 2007; Vizcarra et al. 2011; Zeth et al. 2011). Further, when Capu is 
overexpressed, it can weakly rescue spir mutants. However, Spir overexpression cannot rescue 
capu mutants (Quinlan 2013). The puzzling nature of the Spir and Capu interaction, by which 
they simultaneously seem to cooperate with and antagonize one another, has been best 
described by two differing models: so-called “Hand-off” and “Ping-pong.” 
 
“Ping-pong” 
The Ping-pong model suggests that a Spir-bound (capped) actin filament enhances Capu (Fmn-
2 in the published model) recruitment (i.e. increases the formin’s “on” rate). This recruitment 
occurs via the transient formation of a trimeric complex at the barbed end of a filament, followed 
by Spir’s displacement from the filament by Capu (Fig. 1-3) (Montaville et al. 2014). A Capu-
bound filament can rapidly polymerize due to the processive formin’s elongation activity, until 
Spir again binds/caps the barbed end, evicting Capu. The recruitment of Capu to a barbed end 
is in agreement with the synergy observed in actin assembly assays. However, the inhibition of 
Capu’s processivity by subsequent and rapid Spir interference – as seen in a collaborator’s 
unpublished single-molecule data – conflicts with the oocyte’s requirement of both proteins to 
produce mesh. Furthermore, the authors of this model proposed that a protein like ADF/cofilin 
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must be present to sever Capu-bound filaments and increase the local concentration of barbed 
ends (Fig 1-3, step “4”). However, synergy is consistently observed in the absence of 
ADF/cofilin (Montaville et al. 2015). Finally, Ping-pong’s presumption that synergy occurs 
through Spir’s interaction with filament barbed ends excludes consideration of Dr. Quinlan’s 
paper on Spir, which showed evidence of pointed end binding (Fig. 1-4) (Quinlan et al. 2005). 
 
 
Figure 1-3 – The “Ping-pong” model 
 
From Montaville, et al. (2014). Spir is depicted as being anchored to vesicles, consistent with localization data. (1) 
The barbed end of a filament is capped by Spir. (2) Spir recruits formin to the barbed end. (3) The formin separates 
from Spir and accelerates the elongation of the barbed end. (4) ADF/cofilin severs filaments, creating a pool of 
barbed ends which are recaptured by Spir with (6) or without (5) formin bound. 
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“Hand-off” 
The Hand-off model emphasizes Spir’s known function as a nucleator, and oppositely describes 
its synergy with Capu as occurring at the pointed end of a filament. In this model, Spir is first 
made a better nucleator by dimerization through its interaction with the Capu homodimer (Fig. 
1-5B) (Quinlan 2013). Through use of its eight WH2 domains, the Spir dimer can then assemble 
each strand of the two-start actin filament helix (Fig. 1-5C). In the final step, Spir and Capu 
would likely separate so that the former can nucleate again and the latter can accelerate the 
elongation of the nascent filament (Fig. 1-5D). 
 
This model excludes consideration of Spir’s interaction with filament barbed ends and does not 
consider the role of Spire’s geometry in synergy (Montaville et al. 2014; Pylypenko et al. 2016). 
That is, the vesicular anchoring of Spir depicted in the Ping-pong model aligns with localization 
data and may contribute to the activity of Spir/Capu in vivo. 
Figure 1-4 – SpirNT weakly caps the 
pointed ends of filaments 
 
From Quinlan (2005). The addition of 0.5 or 5 μM 
SpirNT inhibits the rate of depolymerization of 
gelsolin-capped actin filaments. This is a weak 
interaction (μM affinity), as illustrated by the addition 
of only 100 nM Arp2/3. 
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Figure 1-5 – The “Hand-off” model 
 
From Quinlan (2013). (A) Auto-inhibition of Capu is relieved and Spir is dimerized through interaction with one 
another (B). (C) Spire assembles G-actin into a pre-nucleation complex. (D) Capu separates from Spir to elongate the 
barbed end of the nascent filament. 
 
 
The bridging hypothesis 
In unity with both Ping-pong and Hand-off, I hypothesized that a “bridging” event takes place 
between concentrated regions of Spir. In this amended model, I proposed that Spir could serve 
as a paddle and Capu, as the ball. That is, Spir should aid in the initial nucleation of filaments 
and remain bound at, or localized near, their pointed ends. The relegation of Spir to specific 
regions of a cell would allow Capu to processively elongate filaments without much chance of 
eviction until another congregation of Spir were encountered. Localization data are consistent 
with such a model. GFP-Capu is diffuse in the fly oocyte and Spir (both GFP-tagged and 
endogenous protein) is enriched at the cortex (Quinlan 2013; Quinlan et al. 2007). Spir is driven 
to membranes by its C-terminal, modified FYVE (mFYVE) domain which binds negatively 
charged phospholipids (Blatner et al. 2004; Misra and Hurley 1999; Tittel et al. 2015). In the 
mouse oocyte, Spir has been shown to localize to vesicles and new, higher resolution 
microscopy data in the Quinlan lab suggest that Spir also localizes to vesicles in the fly.  
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Three primary experimental approaches were conceived to dissect the mechanism of Spir—
Capu synergy and test the bridging hypothesis: 
1. Bead-based total internal reflection fluorescence microscopy (TIRF-M) 
 As described in the Chapter 2 manuscript, Spir was anchored to vesicle mimics 
with Capu, profilin, and/or capping protein added in solution. The polymerization 
of fluorescently labeled actin was visualized in various conditions 
2. Mutagenesis of Spir WH2 domains 
 As described in Chapter 3 (and Chapter 2, in the case of the WH2-A domain), 
several existing mutants developed in the Quinlan lab were attractive tools for 
testing the contributions of Capu/Spir nucleation and/or capping/elongation to 
synergy in actin assembly 
3. Forster resonance energy transfer (FRET) measurements via fluorescence lifetime 
imaging microscopy (FLIM) 
 As described in Chapter 4, fluorescent Spir and Capu fusions were generated to 
detect their interaction with high spatiotemporal precision in live cells 
  
13 
 
References 
Azoury, Jessica, Karen W. Lee, Virginie Georget, Pascale Rassinier, Benjamin Leader, and 
Marie-Hélène Verlhac. 2008. Spindle Positioning in Mouse Oocytes Relies on a Dynamic 
Meshwork of Actin Filaments. Vol. 18. 
Blatner, Nichole R., Robert V Stahelin, Karthikeyan Diraviyam, Phillip T. Hawkins, Wanjin Hong, 
Diana Murray, and Wonhwa Cho. 2004. “The Molecular Basis of the Differential Subcellular 
Localization of FYVE Domains.” The Journal of Biological Chemistry 279(51):53818–27. 
Bor, Batbileg, Justin S. Bois, and Margot E. Quinlan. 2015. “Regulation of the Formin 
Cappuccino Is Critical for Polarity of Drosophila Oocytes.” Cytoskeleton (Hoboken, N.J.) 
72(1):1–15. 
Bor, Batbileg, Christina L. Vizcarra, Martin L. Phillips, and Margot E. Quinlan. 2012. 
“Autoinhibition of the Formin Cappuccino in the Absence of Canonical Autoinhibitory 
Domains.” 23. 
Bosch, Montserrat, Kim Ho Diep Le, Beata Bugyi, John J. Correia, Louis Renault, and Marie-
France Carlier. 2007. “Analysis of the Function of Spire in Actin Assembly and Its Synergy 
with Formin and Profilin.” Molecular Cell 28(4):555–68. 
Bun, Philippe, Serge Dmitrieff, Julio M. Belmonte, François J. Nédélec, and Péter Lénárt. 2018. 
“A Disassembly-Driven Mechanism Explains F-Actin-Mediated Chromosome Transport in 
Starfish Oocytes.” ELife 7. 
Courtemanche, Naomi and Thomas D. Pollard. 2012. “Determinants of Formin Homology 1 
(FH1) Domain Function in Actin Filament Elongation by Formins.” The Journal of Biological 
Chemistry 287(10):7812–20. 
Dahlgaard, Katja, Alexandre A. S. F. Raposo, Teresa Niccoli, and Daniel St Johnston. 2007. 
“Capu and Spire Assemble a Cytoplasmic Actin Mesh That Maintains Microtubule 
Organization in the Drosophila Oocyte.” Developmental Cell 13(4):539–53. 
Dominguez, Roberto. 2016. “The WH2 Domain and Actin Nucleation: Necessary but 
Insufficient.” Trends in Biochemical Sciences. 
Edwards, Marc, Adam Zwolak, Dorothy A. Schafer, David Sept, Roberto Dominguez, and John 
A. Cooper. 2014. “Capping Protein Regulators Fine-Tune Actin Assembly Dynamics.” 
Nature Reviews Molecular Cell Biology 15(10):677–90. 
Field, Christine M. and Péter Lénárt. 2011. “Bulk Cytoplasmic Actin and Its Functions in Meiosis 
and Mitosis.” Current Biology : CB 21(19):R825-30. 
Goode, Bruce L. and Michael J. Eck. 2007. “Mechanism and Function of Formins in the Control 
of Actin Assembly.” Annual Review of Biochemistry 76(1):593–627. 
Huff, Thomas, Christian S. .. Müller, Angela M. Otto, Roland Netzker, and Ewald Hannappel. 
2001. “β-Thymosins, Small Acidic Peptides with Multiple Functions.” The International 
Journal of Biochemistry & Cell Biology 33(3):205–20. 
14 
 
Ito, Takuto, Akihiro Narita, Tasuku Hirayama, Masayasu Taki, Shohei Iyoshi, Yukio Yamamoto, 
Yuichiro Maéda, and Toshiro Oda. 2011. “Human Spire Interacts with the Barbed End of 
the Actin Filament.” Journal of Molecular Biology 408:18–25. 
Johnstone, O. and P. Lasko. 2001. “Translational Regulation and RNA Localization in 
Drosophila Oocytes and Embryos.” Annual Review of Genetics 35:365–406. 
Leader, Benjamin, Hyunjung Lim, Mary Jo Carabatsos, Anne Harrington, Jeffrey Ecsedy, David 
Pellman, Richard Maas, and Philip Leder. 2002. “Formin-2, Polyploidy, Hypofertility and 
Positioning of the Meiotic Spindle in Mouse Oocytes.” Nature Cell Biology 4(12):921–28. 
Maciver, Sutherland K. and Patrick J. Hussey. 2002. “The ADF/Cofilin Family: Actin-Remodeling 
Proteins.” Genome Biology 3(5):reviews3007. 
Manseau, L., J. Calley, and H. Phan. 1996. “Profilin Is Required for Posterior Patterning of the 
Drosophila Oocyte.” Development (Cambridge, England) 122(7):2109–16. 
Manseau, L. J. and T. Schupbach. 1989. “Cappuccino and Spire: Two Unique Maternal-Effect 
Loci Required for Both the Anteroposterior and Dorsoventral Patterns of the Drosophila 
Embryo.” Genes & Development 3(9):1437–52. 
Misra, Saurav and James H. Hurley. 1999. “Crystal Structure of a Phosphatidylinositol 3-
Phosphate-Specific Membrane-Targeting Motif, the FYVE Domain of Vps27p.” Cell 
97(5):657–66. 
Montaville, Pierre, Antoine Jégou, Julien Pernier, Christel Compper, Bérengère Guichard, 
Binyam Mogessie, Melina Schuh, Guillaume Romet-Lemonne, and Marie-France Carlier. 
2014. “Spire and Formin 2 Synergize and Antagonize in Regulating Actin Assembly in 
Meiosis by a Ping-Pong Mechanism.” PLoS Biology 12(2):e1001795. 
Montaville, Pierre, Sonja Kühn, Christel Compper, and Marie-France Carlier. 2015. “Role of the 
C-Terminal Extension of Formin 2 in Its Activation by Spire and Processive Assembly of 
Actin Filaments.” The Journal of Biological Chemistry M115.681379-. 
Namgoong, Suk, Malgorzata Boczkowska, Michael J. Glista, Jonathan D. Winkelman, Grzegorz 
Rebowski, David R. Kovar, and Roberto Dominguez. 2011. “Mechanism of Actin Filament 
Nucleation by Vibrio VopL and Implications for Tandem W Domain Nucleation.” Nature 
Structural & Molecular Biology 18(9):1060–67. 
Paul, Aditya S. and Thomas D. Pollard. 2009. “Review of the Mechanism of Processive Actin 
Filament Elongation by Formins.” Cell Motility and the Cytoskeleton 66(8):606–17. 
Pechlivanis, Markos, Annette Samol, and Eugen Kerkhoff. 2009. “Identification of a Short Spir 
Interaction Sequence at the C-Terminal End of Formin Subgroup Proteins.” The Journal of 
Biological Chemistry 284(37):25324–33. 
Perrin, Benjamin J. and James M. Ervasti. 2010. “The Actin Gene Family: Function Follows 
Isoform.” Cytoskeleton 67(10):630–34. 
Pfender, Sybille, Vitaliy Kuznetsov, Sandra Pleiser, Eugen Kerkhoff, and Melina Schuh. 2011. 
“Spire-Type Actin Nucleators Cooperate with Formin-2 to Drive Asymmetric Oocyte 
15 
 
Division.” Current Biology : CB 21(11):955–60. 
Pollard, T. D. 1986. “Rate Constants for the Reactions of ATP- and ADP-Actin with the Ends of 
Actin Filaments.” The Journal of Cell Biology 103(6 Pt 2):2747–54. 
Pollard, T. D. and J. A. Cooper. 1986. “Actin and Actin-Binding Proteins. A Critical Evaluation of 
Mechanisms and Functions.” Annual Review of Biochemistry 55(1):987–1035. 
Pylypenko, Olena, et al. Rock. 2016. “Coordinated Recruitment of Spir Actin Nucleators and 
Myosin V Motors to Rab11 Vesicle Membranes.” ELife 5:213–21. 
Quinlan, Margot E. 2013. “Direct Interaction between Two Actin Nucleators Is Required in 
Drosophila Oogenesis.” Development (Cambridge, England) 140(21):4417–25. 
Quinlan, Margot E., John E. Heuser, Eugen Kerkhoff, and R. Dyche Mullins. 2005. “Drosophila 
Spire Is an Actin Nucleation Factor.” 
Quinlan, Margot E., Susanne Hilgert, Anaid Bedrossian, R. Dyche Mullins, and Eugen Kerkhoff. 
2007. “Regulatory Interactions between Two Actin Nucleators, Spire and Cappuccino.” The 
Journal of Cell Biology 179(1):117–28. 
Theriot, J. A. and T. J. Mitchison. 1993. “The Three Faces of Profilin.” Cell 75(5):835–38. 
Theurkauf, W. 1994. “Premature Microtubule-Dependent Cytoplasmic Streaming in Cappuccino 
and Spire Mutant Oocytes.” Science 265(5181):2093–96. 
Theurkauf, W. E., S. Smiley, M. L. Wong, B. M. Alberts, Z. Bryant, H. Ruohola-Baker, and L. 
Manseau. 1992. “Reorganization of the Cytoskeleton during Drosophila Oogenesis: 
Implications for Axis Specification and Intercellular Transport.” Development (Cambridge, 
England) 115(4):923–36. 
Tittel, Janine, Tobias Welz, Aleksander Czogalla, Susanne Dietrich, Annette Samol-Wolf, 
Markos Schulte, Petra Schwille, Thomas Weidemann, and Eugen Kerkhoff. 2015. 
“Membrane Targeting of the Spir·formin Actin Nucleator Complex Requires a Sequential 
Handshake of Polar Interactions.” The Journal of Biological Chemistry 290(10):6428–44. 
Vizcarra, Christina L., Batbileg Bor, and Margot E. Quinlan. 2014. “The Role of Formin Tails in 
Actin Nucleation, Processive Elongation, and Filament Bundling * □ S.” Published JBC 
Papers in Press. 
Vizcarra, Christina L., Barry Kreutz, Avital A. Rodal, Angela V Toms, Jun Lu, Wei Zheng, Margot 
E. Quinlan, and Michael J. Eck. 2011. “Structure and Function of the Interacting Domains 
of Spire and Fmn-Family Formins.” 
Vizcarra, Christina L. and Margot E. Quinlan. 2017. “Actin Filament Assembly by Bacterial 
Factors VopL/F: Which End Is Up?” The Journal of Cell Biology 216(5):1211–13. 
Xu, Yingwu, James B. Moseley, Isabelle Sagot, Florence Poy, David Pellman, Bruce L. Goode, 
and Michael J. Eck. 2004. “Crystal Structures of a Formin Homology-2 Domain Reveal a 
Tethered Dimer Architecture.” Cell 116(5):711–23. 
16 
 
Zeth, Kornelius, Markos Pechlivanis, Annette Samol, Sandra Pleiser, Clemens Vonrhein, and 
Eugen Kerkhoff. 2011. “Molecular Basis of Actin Nucleation Factor Cooperativity: Crystal 
Structure of the Spir-1 Kinase Non-Catalytic C-Lobe Domain (KIND)•formin-2 Formin SPIR 
Interaction Motif (FSI) Complex.” The Journal of Biological Chemistry 286(35):30732–39. 
 
  
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: Spire stimulates nucleation by Cappuccino and 
binds both ends of actin filaments 
  
18 
 
Spire stimulates nucleation by Cappuccino and binds both ends of 
actin filaments  
  
  
  
  
Alexander O. Bradley1, Christina L. Vizcarra1,*, Hannah M. Bailey1, Margot E. Quinlan1,2,#  
  
1Department of Chemistry and Biochemistry and 2Molecular Biology Institute, 
University of California Los Angeles, 607 Charles E. Young Drive, Los Angeles, 
CA 90095, USA.  
  
*current address:  Department of Chemistry, Barnard College, New York, USA.  
   
#corresponding author:  margot@chem.ucla.edu  
  
 
 
 
 
Abstract   
An actin mesh fills both mouse and fly oocytes. The meshes are built by a conserved 
mechanism and used to establish polarity. Two actin nucleators, Spire and Cappuccino, 
collaborate to build actin filaments that connect vesicles and the cortex. Direct interaction 
between Spire and Cappuccino is required for in vitro synergistic actin assembly; however, we 
understand little about why the interaction is necessary. To mimic the geometry of Spire and 
Cappuccino in vivo, we immobilized Spire on beads. We found that increased nucleation is a 
major part of synergy and that Spire alone binds both barbed- and pointed-ends of actin 
filaments. We identified Spire’s barbed-end binding domain. Partial rescue of fertility by a loss-
of-function mutant indicates that barbed-end binding is not necessary for Spire’s in vivo function, 
but that it may play a role under normal circumstances. We propose that Spire stimulates 
nucleation by Cappuccino in a manner similar to the collaboration between APC and mDia1.  
 
 
 
Keywords: Spire, Cappuccino, actin, Drosophila, cytoskeleton, nucleation, microscopy, mesh, 
streaming, oogenesis  
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Introduction 
Cells contain a variety of actin-based structures that fulfill distinct functional roles. The actin 
cytoskeleton is malleable due to dynamic structural regulation by a range of distinct actin-
binding proteins. The first step to building a structure is generally catalysis of new actin 
filaments, so-called nucleation. Both a kinetic barrier and certain actin binding proteins, such as 
profilin, prevent spontaneous nucleation in the cell. Instead, actin nucleators stimulate this 
process in highly regulated manners. There are three known classes of actin nucleators that 
function by distinct mechanisms: the Arp2/3 complex, formins, and tandem-WH2 domain 
nucleators. A developing trend is that none of these proteins work independently. Effector 
proteins can inhibit or enhance the activity of actin nucleators. Usually, the effector is not a 
nucleator. In some cases, two independent nucleators also work together. A poorly understood 
example of such interplay is the collaboration between Cappuccino (Capu, a formin) and Spire 
(Spir, a tandem-WH2 nucleator).   
 
Both Spir and Capu are required for oogenesis. This discovery was first made in Drosophila and 
subsequently demonstrated in mouse (Manseau and Schupbach, 1989; Leader et al., 2002; 
Pfender et al., 2011). In both cases, Capu (or Fmn-2, one of two mammalian homologs) and 
Spir (or mSpire, referring to mammalian homologs, Spire-1 and Spire-2) build a mesh of actin 
that fills the oocyte (Dahlgaard et al., 2007; Schuh and Ellenberg, 2008; Azoury et al., 2008; 
Pfender et al., 2011). The discovery that both Spir and Capu are actin nucleators led to the 
question of why two nucleators would be needed to build one structure (Quinlan et al., 2005). 
We now know that direct interaction between Spir and Capu is required for their function 
(Quinlan, 2013). Detailed biochemical analyses and structural biology provide insight into the 
interaction: the N-terminal Spir-KIND domain binds the C-terminal Capu-tail with ~100 nM 
affinity (Fig. 1) (Quinlan et al., 2007; Vizcarra et al., 2011; Pechlivanis et al., 2009; Zeth et al., 
2011). However, our understanding of the functional consequences of the interaction remain 
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incomplete. Capu, like all formins, is a dimer. It can bind two copies of Spir and, thereby, 
accelerate actin assembly by Spir (Quinlan et al., 2007; Vizcarra et al., 2011). In contrast, Spir’s 
KIND domain inhibits nucleation by Capu and competes with barbed ends for Capu binding, 
effectively inhibiting Capu’s ability to accelerate actin assembly (Quinlan et al., 2007; Vizcarra et 
al., 2011). However, when a human Spire-1 construct, containing both the KIND domain and 
four tandem WH2 domains, is mixed with the C-terminal half of Fmn-2, actin assembly is greatly 
enhanced (Montaville et al., 2014). So-called ping-ponging – Spir and Fmn-2 alternately binding 
to the barbed end of filaments – is observed and was proposed to account for synergistic actin 
assembly (Montaville et al., 2014).  
  
Spir is enriched at the cortex of the Drosophila oocyte, localizes to Rab11-positive vesicles in 
mouse oocytes, and the C-terminal mFYVE domain of mSpire-1 binds phospholipids (Quinlan et 
al., 2007; Quinlan, 2013; Pfender et al., 2011; Tittel et al., 2015). While Fmn-2 is also observed 
on Rab11-positive vesicles in mouse ooctyes, GFP-Capu appears diffuse throughout the 
Drosophila oocyte (Schuh, 2011; Dahlgaard et al., 2007; Quinlan, 2013). In the mouse oocyte, 
Rab11-positive vesicles that contain mSpire, Fmn-2, and Myosin V are at nodes of the actin 
mesh that fills the oocyte (Schuh, 2011). Mesh dynamics contribute to nucleus positioning and 
long distance transport of the Rab11-positive vesicles toward the cell cortex (Holubcová et al., 
2013; Almonacid et al., 2015; Ahmed et al., 2018). A model to account for the long distance 
transport includes mSpire/Fmn-2-nucleated actin filaments growing with their barbed ends 
remaining near the vesicles, creating tracks that myosin V on neighboring vesicles can walk 
along, pulling vesicles together (Schuh, 2011). When ping-ponging was observed, Montaville et 
al. (Montaville et al., 2014) expanded on this model, proposing that barbed ends of filaments 
and/or pre-nuclei are recruited by vesicle-bound mSpire and handed off to Fmn-2 to stimulate 
elongation.    
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In order to learn more about how Spir and Capu interact to build actin filaments and structures, 
we combined biochemistry and fly genetics. We developed a bead-based assay, in which we 
attached the N-terminal half of Spir (SpirNT) to beads and added free C-terminal half of Capu 
(CapuCT), based on reported localization data (see Fig. 2-1A for construct definitions). Through 
this work we found that beads decorated with SpirNT and CapuCT (CapuCT/SpirNT-beads) 
nucleate filaments that grow with their barbed ends away from beads, protected by CapuCT, 
opposite to the polarity proposed earlier. We found that SpirNT alone on beads (SpirNT-beads) 
nucleates filaments oriented the same way. We also found that SpirNT-beads retain the pointed 
ends of filaments with a dwell time of ~100 seconds while neighboring SpirNT-beads capture 
the barbed ends of filaments for several hundreds of seconds. These data resolve an 
outstanding question in the literature about Spir’s association with filament ends – it binds both 
ends. We also identified the domain necessary for Spir’s high-affinity barbed-end binding. 
Surprisingly, barbed end binding is not necessary for oogenesis and loss of barbed-end binding 
increases Spir/Capu synergy in vitro. These genetic and biochemical data indicate that ping-
ponging at the barbed end is neither the dominant source of synergy nor necessary in vivo. 
Instead, we propose that Spir and Capu collaborate by a mechanism in which Spir promotes 
Capu’s nucleation activity through its independent nucleation activity, similar to APC/mDia1 
synergy (Okada et al., 2010; Breitsprecher et al., 2012).  
 
Results  
WH2 domains are necessary for Drosophila oogenesis   
The Spir-KIND domain inhibits CapuCT in pyrene-actin assays (Quinlan et al., 2007; Vizcarra et 
al., 2011). However, genetics indicate that Spir and Capu both play positive roles in oocyte 
mesh formation (Manseau and Schupbach, 1989; Dahlgaard et al., 2007; Quinlan, 2013). 
Combined, these data suggest that Spir’s WH2 domains contribute to function in vivo. To 
formally test whether actin binding is required, we used full-length Spir (CG10076, splice variant 
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PB) with a C-terminal mEGFP tag in a genetic rescue assay. In each of Spir’s four WH2 
domains, we mutated three conserved, hydrophobic residues which contact actin (Fig. 2-1A) 
(Kelly et al., 2006; Chereau et al., 2005). These mutations were previously shown to 
dramatically decrease, if not abolish, actin monomer binding (Quinlan et al., 2005). In vitro, 
SpirNT with all of these mutations (SpirNT(A*B*C*D*)) does not accelerate actin assembly (Fig. 
2-8A) (Quinlan et al., 2005). We previously demonstrated that expression of wild-type Spir-GFP, 
driven by germline specific nanos-Gal4-vp16, is sufficient to rescue fertility in flies that lack 
endogenous Spir (Table 2-1) (Quinlan, 2013). In contrast, expression of Spir(A*B*C*D*)-GFP 
failed to rescue fertility (hatch rate < 2%, Table 2-1). In oocytes expressing only Spir(A*B*C*D*)-
GFP, the actin mesh is absent and streaming is premature, consistent with loss of actin 
assembly activity and loss of fertility (Fig. 2-1C-E). Thus, we conclude that actin binding by at 
least one of Spir’s WH2 domains is necessary for actin assembly and oogenesis.  
  
Barbed ends project away from CapuCT/SpirNT-beads  
In order to learn more about how Spir and Capu interact to build actin filaments and structures, 
we developed a bead-based assay. Spir is enriched at the cortex of the Drosophila oocyte, 
localizes to Rab11-positive vesicles in mouse oocytes, and the C-terminal mSpire-mFYVE 
domain binds phospholipids (Quinlan et al., 2007; Quinlan, 2013; Pfender et al., 2011; Tittel et 
al., 2015). While Fmn2 is also observed on vesicles in the mouse oocyte, GFP-Capu appears 
diffuse throughout the Drosophila oocyte (Schuh, 2011; Quinlan, 2013). Based on these data, 
we immobilized SpirNT on beads and added CapuCT in solution. To do so, we biotinylated a C-
terminal Avitag on SpirNT and mixed it with CapuCT and streptavidin-coated beads (Fig. 2-1B). 
We introduced the decorated beads to a sparsely biotinylated flow chamber and imaged them 
by total internal reflection fluorescence (TIRF) microscopy. When we added actin (20% OG-
actin) and profilin to the flow chamber, extensive and rapid polymerization followed (Fig. 2-2A, 
Video 1). 
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Figure 2-1 – WH2 domains are necessary for oogenesis 
 
(A) Domain architecture of Drosophila melanogaster Cappuccino (Capu), Spire (Spir), and truncations 
used. CID, Capu Inhibitory Domain (orange); FH1/FH2, Formin Homology domains (1, dark blue; 2, red); 
T, Tail (yellow); KIND, Kinase Noncatalytic C-lobe Domain (purple); WH2, Wiskott-Aldrich syndrome 
Homology domains (light blue); mFYVE, Modified FYVE (zinc finger) domain (green). Spir has four WH2 
domains, named WH2-A through -D. The sequence of WH2-A and mutations that disrupt its actin binding 
are shown. (B) Bead experiment methodology. To decorate streptavidin-coated microspheres (gold) with 
SpirNT, and to bind the microspheres to the coverslip, biotin (green) is conjugated both to coverslips and 
to SpirNT. Two potential orientations of the actin filament distinguish Spir’s primary activities at each end: 
capping filaments at their barbed ends (left) and nucleating filaments from their pointed ends (right). (C) 
Cartoon of a stage 9 egg chamber. P, Posterior. (D – F) Stage 9 egg chambers dissected from flies with a 
spir null background, expressing Spir-GFP (D), Spir(A*B*C*D*)-GFP (E), or Spir(A*)-GFP (F, F’). Egg 
chambers were stained with fluorescently-labeled phalloidin to detect the presence or absence of mesh 
(left images) and standard deviation projections of autofluorescent yolk granule positions over 2 minutes 
(right images) show the extent of ooplasmic streaming. Expression of Spir(A*)-GFP results in a mixture of 
failed (F) and successful rescues (F’). 
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Two groups proposed that Spir/Capu-coated vesicles have filaments with barbed ends apposed 
to the vesicle and pointed ends growing away (Fig. 2-1B) (Montaville et al., 2014; Schuh, 2011). 
We tested this model by examining the orientation of filaments growing off of CapuCT/SpirNT-
beads. By lowering the concentration of actin (600 nM), we decreased nucleation such that we 
could track individual filaments. Under these conditions, we observed filaments growing from 
but “retained” at the beads (Videos 2 and 3). We carefully analyzed 9 of 32 individual filaments 
observed. In every case, fiducial marks which do not move with respect to the bead, and 
increased fluorescence intensity at filament ends (i.e. ends brighter due to addition of 
unbleached monomers (Kovar and Pollard, 2004)), away from the bead, indicate that barbed 
ends grow away from the bead surface (Fig. 2-2B, Video 3). We expected to see the opposite 
case with Capu directly conjugated to the beads. For unknown reasons, Capu was not 
functional when attached to beads through a number of different linkers. Instead, we conjugated 
the formin mDia1 to beads. In this case, fiducial marks were displaced at the rate of filament 
elongation and the addition of unbleached monomers was no longer observed at the filament 
end away from the bead (Fig. 2-2C, Video 4), consistent with barbed-end growth at the bead 
surface. Together these data demonstrate that CapuCT/SpirNT-beads nucleate filaments with 
barbed ends growing away from the bead and suggest that CapuCT separates from SpirNT to 
elongate the filament.  
  
Spir beads retain the pointed ends of nucleated actin filaments  
A dense collection of filaments emanated radially from CapuCT/SpirNT-beads. Because we 
concluded that CapuCT-mediated elongation proceeded away from the beads, the density of 
actin near the bead surface suggested that the pointed ends of filaments could be retained by 
Spir. We repeated the experiments with SpirNT-beads, without added CapuCT or profilin, and 
observed similar patterns (Fig. 2-3A, Video 5). We found that nucleation by SpirNT-beads was  
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Figure 2-2 – Barbed ends project away from CapuCT/SpirNT-beads 
 
(A) Actin assembles off of CapuCT/SpirNT-beads. See also, Video 1. (B) A single filament is nucleated 
and retained by a bead. Kymograph (bottom) shows bleaching of filament regions closest to the bead and 
new, labeled actin added away from the bead, indicating growth away from the bead. See also, Video 3. 
(C) A single filament is nucleated and elongated by a bead coated with mDia1. Filament growth is 
accelerated by the processive formin and profilin. Fiducial marks (e.g. dark, diagonal lines) in the 
kymograph are displaced from the bead at the rate of elongation, indicating growth at the bead. See also, 
Video 4. 
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suppressed enough to observe individual filaments when profilin was added back (Fig. 2-3B).  
 
We again observed filaments growing from and retained at the bead surface (Fig. 2-3C and 
Video 6). The distribution of filament dwell times was well fit by a single exponential with an off 
rate of 0.007 ± 0.003 s-1 (Fig. 2-3D). We note that retention of filaments by SpirNT-beads 
occurred independent of profilin (Fig. 2-8G and Video 7). Furthermore, neither filament end 
was observed to interact with beads coated with Spir-KIND and CapuCT (Fig. 2-8F), indicating 
that retention is specifically mediated by Spir-WH2 domains.  
  
We did not assume that filaments were oriented with their barbed ends out when nucleated by 
SpirNT-beads because Spir has been reported to bind both the barbed and pointed ends of 
filaments (Quinlan et al., 2005; Bosch et al., 2007; Ito et al., 2011). mSpire1 caps barbed ends 
with high affinity and SpirNT binds pointed ends weakly (nM vs µM Kds) (Bosch et al., 2007; 
Montaville et al., 2014; Quinlan et al., 2005). We closely analyzed 10 of the 70 filaments 
included in the retention data set. All ten filaments, growing from SpirNT-beads, displayed 
fiducial marks which did not move with respect to the bead and typically had brighter filament 
ends away from the beads consistent with barbed ends being oriented away from the beads 
(Fig. 2-3C). Thus, we conclude that barbed ends grow away from SpirNT-beads and that 
SpirNT is sufficient to retain the pointed ends of actin filaments for >100 seconds.  
  
SpirNT-beads capture and cap the barbed ends of actin filaments  
When we examined the dense actin networks emanating from beads, we also observed 
apparent connections between neighboring beads (Fig. 2-3A). This pattern suggested to us that 
the barbed ends of actin filaments could also be associated with the beads. Under conditions 
where individual filaments could be tracked, we observed the “capture” of filaments (Fig. 2-4).  
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Figure 2-3 – SpirNT-beads retain the pointed ends of nucleated actin filaments 
 
(A) SpirNT-beads, in the absence of Capu and profilin, also potently polymerize actin. The highlighted 
region (gold) is magnified and pseudocolored (right) to emphasize the enrichment of actin filaments 
between beads. See also, Video 5. (B) Nucleation by SpirNT-beads is suppressed by profilin. When 
added at 1 μM (gold box), profilin permits the observation of several, single filaments per bead. (C) 
SpirNT-beads also retain nucleated filaments. G, Growth; B, Bead. Fiducial marks (dark, horizontal lines) 
in the kymograph are not displaced as the filament elongates, indicating growth away from the bead. See 
also, Video 6. (D) Dwell times of filament pointed ends on beads. Nucleated and retained filaments were 
tracked from SpirNT-beads in the presence of 1 μM actin and 1 μM profilin. All bead-associated filaments 
were counted unless obviously captured from solution or > 1 μm in length when first visible. The data are 
well fit by a single exponential (koff = 0.007 ± 0.003 s-1, n = 70 filaments; 4 independent  
experiments). 
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The association of captured filaments with Spir beads often outlasted the single-filament 
imaging window (10+ minutes), precluding measurement of an off rate and suggesting that the 
interaction was distinct from retention.  
  
In addition to seeing filaments between beads, we often observed capture of free filaments. We 
probed the orientation of captured filaments using two colors of actin. We initiated elongation in 
the presence of Cy3B-actin and stabilized these filaments with phalloidin after several minutes. 
Adding a limiting pool of OG-actin (600 nM) plus profilin to favor barbed end growth, we 
observed that – whether the filament had both ends free (as shown) or one end retained by a 
bead – only the barbed ends of filaments were captured by beads (Fig. 2-4A, Video 8). 
Filaments captured by beads did not grow measurably (Fig. 2-4A). Occasionally, we observed 
the release of a barbed end, following capture. In these cases, the filament resumed elongation 
at the same rate as before capture (Fig. 2-4A). As noted above, barbed ends do not interact 
with CapuCT/Spir-KIND-beads (Fig. 2-8F). These data indicate that the barbed ends are 
capped by Spir-WH2 domains, as opposed to being non-specifically stuck to the beads or KIND 
domain.   
  
To further test the phenomenon of filament capture, we added capping protein and CapuCT to 
the experiment. Under these conditions, the sustained and accelerated growth of retained 
filaments confirmed that CapuCT separates from SpirNT to elongate filament barbed ends (Fig. 
2-4B). These filaments were still captured by beads, suggesting that SpirNT displaces CapuCT 
from the barbed end (Fig. 2-4B, Video 9). Together these data demonstrate that – with or 
without CapuCT present – Spir-beads can nucleate and retain the pointed ends of actin 
filaments, while neighboring beads can capture and cap their barbed ends.  
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Figure 2-4 – SpirNT-beads capture and cap the barbed ends of actin filaments 
 
(A) Nucleated filaments (green) grow only at their barbed ends (magenta). A free filament (dashed 
outline) diffuses and grows until it is captured by a SpirNT-bead (solid triangle). The filament resumes 
growth once released by the bead (open triangle). The kymograph shows that the growing, barbed end 
(magenta) is captured/capped by Spir and resumes growth after release. See also, Video 8. (B) Two 
filaments (cyan triangles) nucleated by a SpirNT/CapuCT-bead (“A”) are retained for over 5 minutes. 
Their barbed ends are captured (gold triangles) by other CapuCT/SpirNT-beads (“B” and “C”). 
Accelerated growth of these filaments (~20 subunits/sec) in the presence of profilin and capping protein 
indicates that CapuCT is elongating and protecting their barbed ends. Filaments did not measurably 
grow, following capture, suggesting that CapuCT is displaced and that the barbed end is bound by SpirNT 
upon capture. See also, Video 9. 
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Spir’s WH2-A binds filament barbed ends and reduces actin nucleation  
Each of Spir’s four WH2 domains contributes differently to nucleation and they bind actin 
monomers with a range of affinities (from ~100 nM – 1.1 µM) (Quinlan et al., 2005; Rasson et 
al., 2015). We reasoned that the most N-terminal WH2 domain, WH2-A, binds barbed ends of 
filaments, based on our earlier observation that isolated WH2-A is the only Spir-WH2 domain 
that slows filament growth (Rasson et al., 2015). To test the contribution of WH2-A to barbed 
end binding, we first established that wild-type SpirNT caps barbed ends in a seeded elongation 
assay, as has been shown for mSpire-1 (Bosch et al., 2007). In the presence of actin seeds, 
monomers, and profilin, SpirNT potently inhibits elongation (Fig. 2-5A). The dose dependence 
of inhibition indicates an apparent affinity of SpirNT for barbed ends of 20 ± 3 nM, similar to that 
reported for mSpire-1 (Fig. 2-5B). We then mutated three conserved hydrophobic residues in 
WH2A of SpirNT (SpirNT(A*); Fig. 2-1A) to remove actin monomer binding by this domain 
alone. When added to the seeded elongation assay, SpirNT(A*) was essentially unable to inhibit 
elongation (Fig. 2-5A,B). Thus, a functional WH2-A domain is necessary for high affinity, 
barbed-end capping.  
  
In standard pyrene-actin assays, we found that SpirNT(A*) assembles actin more potently than 
wild type SpirNT (Fig. 2-5C and 2-8C). Of note, the plateau of pyrene traces does not decrease 
at high concentrations as is seen for wild type SpirNT, suggesting that this mutant is not a 
potent monomer sequesterer (Fig. 2-5C) (Quinlan et al., 2005). We next attached biotinylated 
SpirNT(A*) to beads and added actin and profilin. Consistent with increased activity in pyrene 
assays, we observed faster accumulation of filaments from SpirNT(A*)-beads compared to wild 
type SpirNT-beads (Fig. 2-5D, Video 10). To compare nucleation rates on beads, we measured 
the integrated intensity of actin within a band 1.6 μm away from the beads. At this proximity, we 
are minimally sensitive to filament elongation and interpret the intensity as proportional to the  
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Figure 2-5 – Spir’s WH2-A binds filament barbed ends and reduces actin nucleation 
 
(A) Seeded elongation is inhibited by the addition of 12.5 – 200 nM SpirNT (shades of blue). The addition 
of 200 nM SpirNT(A*) has no effect (purple). (B) Dose dependent elongation rates are plotted for three 
experiments. The data are fit by a quadratic equation, indicating that SpirNT binds the barbed end with a 
Kd of 20 ± 3 nM. The line is a fit to all data points and the Kd is the average of three independent 
experiments. Inhibition by SpirNT(A*) is negligible. (C) SpirNT(A*) assembles actin more potently than 
wild type SpirNT in a pyrene-actin assembly assay. Plateaus that are independent of Spire concentration 
suggest that SpirNT(A*) does not sequester actin like SpirNT (compare solid lines). (D) SpirNT(A*)-beads 
nucleate more potently than wild type. See also, Video 10. (E) Quantification of filament pointed end dwell 
times on beads (koff = 0.011 ± 0.003 s-1,n = 33 filaments; 3 independent experiments). The off rate is not 
statistically different from wild type (data from Fig. 3D). 
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number of filaments; that is, nucleation. We measured time courses and calculated the rates of 
increase in OG-actin signal. The difference in rates indicates that nucleation by SpirNT(A*) is 
~3x stronger than wild type SpirNT in the presence of profilin (Fig. 2-6D,E). We also measured 
the dwell times of filaments retained by SpirNT(A*)-beads. The off rate is not significantly 
different than that of wild type (koff(WT) = 0.007 ± 0.003 s-1, koff(A*) = 0.011 ± 0.003 s-1, Student’s t-
test, p = 0.98, Fig. 2-5E), indicating that WH2-A does not play an important role in filament 
retention. Notably, we rarely observed apparent capture events by SpirNT(A*)-beads. In several 
cases, filaments appeared to be close enough to a neighboring bead for capture for tens of 
seconds, but sustained association of the barbed end with beads was rare. Taken together, 
these data are consistent with the requirement of functional WH2-A for high affinity barbed end 
binding and demonstrate that this domain is not critical for pointed end binding.   
  
Synergy between Spir and Capu does not require barbed end binding  
Previously, synergistic actin assembly by mSpire-1 and Fmn-2 was described:  the rate of actin 
assembly by mSpire-1+Fmn-2 is greater than the sum of assembly rates of the individual 
nucleators (Montaville et al., 2014). We confirmed that SpirNT and CapuCT exhibit a similar 
synergistic effect in pyrene-actin assembly assays (Fig. 2-6A and 2-8D). In the presence of 
profilin, the assembly rate of SpirNT+CapuCT (based on the t1/2 at ≥ 40 nM SpirNT) was 6x 
and15x faster than CapuCT or SpirNT, respectively (Fig. 2-6B). As seen for the mammalian 
paralogs, direct interaction is required for synergy: SpirNT(Y232K), a mutant that does not bind 
Capu, does not synergize with CapuCT (Vizcarra et al., 2011; Montaville et al., 2014) (Fig. 2-
8E). Likewise, Spir’s actin binding activity is required, as demonstrated by the absence of 
synergy when SpirNT(A*B*C*D*) is added to CapuCT (Fig. 2-6B and 2-8B).  
  
Montaville et al. (Montaville et al., 2014) concluded that actin assembly was enhanced by 
mSpire1 and Fmn-2 alternately binding the barbed end, which they dubbed the “ping-pong” 
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mechanism. Given that SpirNT(A*) does not bind to or capture barbed ends, we assume that 
ping-ponging is not possible with this mutant. However, when we tested SpirNT(A*) in the 
pyrene synergy assay, we found ~3x enhanced synergy (based on the t1/2 at ≥ 40 nM SpirNT), 
as opposed to loss of activity (Fig. 2-6A,B and S1D). The dose dependence of synergy is 
indistinguishable for SpirNT and SpirNT(A*) (Fig. 2-6B). We speculate that dose dependence is 
a function of Spir-KIND/Capu-tail binding, which should not be affected in SpirNT(A*). These 
data lead us to propose that nucleation – not just elongation – is enhanced when SpirNT and 
CapuCT interact.  
  
To test more directly whether nucleation is increased by SpirNT and CapuCT collaborating, we 
returned to the bead assay. When CapuCT/SpirNT-beads are mixed with actin and profilin, we 
observe potent nucleation (Fig. 2-6C). Consistent with nucleation being a significant element of 
Spir/Capu synergy, the rate of filament formation is more than 6x greater than nucleation in the 
absence of Capu (Figs. 2-6C,D,E). Nucleation of profilin-actin by CapuCT/SpirNT(A*)-beads 
was even stronger than wild type (4x) and the synergy more pronounced (9.5x vs SpirNT(A*)-
beads in the absence of Capu) with the actin signal saturating at the measured 1.6 μm radius 
within ~2 minutes (Fig. 2-6C,D). Thus, nucleation is potently enhanced when SpirNT and 
CapuCT are combined and loss of barbed end binding by SpirNT leads to even stronger 
nucleation in the presence and absence of CapuCT. These data support our conclusion that 
enhanced nucleation is a major source of synergy.  
  
Barbed end binding is not necessary for oogenesis  
Finally, we asked whether barbed-end binding is necessary for Drosophila oogenesis. To do so, 
we tested Spir(A*)-GFP, using the rescue strategy described above. We found that, when driven 
by nanos-Gal4-vp16, fertility was partially rescued (40%, Table 2-1). The fertility rescue is about 
two thirds as effective for Spir(A*)-GFP when compared to the wild type transgene.  
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Figure 2-6 – Synergy between Spir and Capu does not require barbed end binding 
 
(A) Actin assembly assays in the presence of profilin and capping protein. CapuCT alone and SpirNT 
alone (solid and dashed gray lines) are weak under these conditions, but synergize in assembly when 
combined (blue). SpirNT(A*) synergizes more potently with CapuCT (magenta). (B) Dose dependence of 
t1/2. Solid circles are SpirNT or CapuCT alone (blue and green, respectively; one representative 
experiment shown for each). Open circles indicate the addition of both proteins. SpirNT, blue; SpirNT(A*), 
magenta (n = 3 independent experiments, each); SpirNT(A*B*C*D*), orange (one representative 
experiment shown at each concentration). Raw data are shown in Fig. S1B,D. (C) Nucleation is stronger 
on CapuCT/SpirNT(A*)-beads than CapuCT/SpirNT-beads. (D) Quantification of experiments like those 
shown in (C) and Fig. 5D. Fluorescence around beads is expressed as an average percentage of initial 
values over time (n ≥ 4 beads, n ≥ 2 independent experiments per condition). See methods for description 
of data transformation. Data plotted were obtained using 1 μm diameter beads, 1 μM actin, and 1 μM 
profilin, with or without CapuCT (solid or dashed lines, respectively). S, SpirNT-beads; P, profilin; C, 
CapuCT. SpirNT-bead data are plotted in blue and SpirNT(A*)-bead data, in magenta. (E) Rates of 
fluorescence increase, from (D). Mean ± SEM are indicated for each condition. The initial 50 s of images 
(t = ~30–80 s) were used to determine rates. A Student’s t-test was performed on each pair of conditions 
indicated (black brackets). ***, p < 0.0001. The difference in activity by SpirNT(A*/WT)-beads (without 
Capu) was not statistically significant (unequal variance; p = 0.13). 
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Consistently, the mesh is present and streaming is properly regulated in about half of the 
oocytes (Fig. 2-1F,F’) Thus, barbed-end binding is not necessary for mesh formation or 
oogenesis, though the fertility decrease suggests that it may contribute under normal conditions. 
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Table 2-1 – Fertility experiments 
 
Transgene (spir1/Df(2L)Exel6046)a % Hatchedb Number countedb 
Spir-GFPc 59 606 
Spir(A*B*C*D*)-GFP <2 431 
Spir(A*)-GFP 40 619 
 
a Genetic background is in parentheses. 
b % hatched is reported as the average of at least three independent trials. Number counted is the sum of 
eggs counted from all trials. 
c (Quinlan 2013) 
 
% hatched is measured 24 hours after egg lay. ~95% w1118 hatch; 0% spir1/Df(2L)Exel6046 hatch. 
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Discussion  
Spir binds both ends of actin filaments  
The bead assay facilitated observation of several steps in actin assembly by Spir and Capu. We 
found that filaments nucleated on CapuCT/SpirNT-beads grow with their barbed ends away 
from the bead with enhanced rates, accelerated by CapuCT. Thus, SpirNT and CapuCT 
separate after nucleation, consistent with genetics results (Quinlan, 2013). We also found that 
CapuCT-bound barbed ends would subsequently stop growing if they encountered 
CapuCT/SpirNT-beads, suggesting that the barbed-end was passed from CapuCT to SpirNT. 
To our surprise, we found that SpirNT-beads were sufficient to bind both ends of actin filaments. 
There are conflicting reports regarding filament-end binding for two classes of tandem-WH2 
nucleators:  Spir and VopF/L (Liverman et al., 2007; Yu et al., 2011; Pernier et al., 2013, 2016; 
Burke et al., 2017). The N-termini of WH2 domains bind actin monomers between subdomains 
1 and 3 of actin – the surface exposed at the barbed ends of filaments (Chereau et al., 2005; 
Hertzog et al., 2004). It was, therefore, reasonable to expect tandem-WH2 nucleators to 
associate with filament barbed ends and surprising when both VopL and Spir were reported to 
bind filament pointed ends (Quinlan et al., 2005; Namgoong et al., 2011; Yu et al., 2011). Spir 
nucleates filaments with free barbed ends and inhibits depolymerization of gelsolin-capped 
filaments, albeit weakly (Quinlan et al., 2005). Spir also caps barbed ends of growing filaments 
but with nanomolar affinity (Bosch et al., 2007; Montaville et al., 2014). Here we present 
evidence that these apparently conflicting data are both correct. This is not unprecedented. 
Namgoong et al. (Namgoong et al., 2011) and Burke et al. (Burke et al., 2017) reported that 
VopL/F can interact with both ends of actin filaments, depending on the conditions.   
  
Earlier, we did not observe barbed-end binding by Spir when assayed by inhibition of 
depolymerization (Quinlan et al., 2005). We now report high affinity barbed-end binding in 
inhibition of elongation assays. Possibly, Spir only binds barbed ends in the presence of actin 
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monomers as was described for N-Wasp (Co et al., 2007). This contrasts with VopL/F that 
primarily bind barbed ends of preformed filaments in the absence of free monomer (Burke et al., 
2017). The first of Spir’s tandem WH2 domains, WH2-A, is necessary to cap barbed ends. It is 
curious that removing function of this WH2 domain increases the activity of SpirNT. In earlier 
work, we did not observe a significant difference in actin assembly, with or without WH2-A 
(Quinlan et al., 2005). The original data were acquired with higher concentrations of both SpirNT 
and actin, which may have masked the difference. In addition, the data were acquired with a 
slightly longer construct: 1-520 vs 1-490. One possible explanation for enhanced actin 
nucleation by SpirNT(A*) is that loss of capping leads to fewer so-called SA4 complexes (Spir 
bound to four actin monomers). We and others observed SA4 complexes when Spir is mixed 
with actin under polymerizing conditions (Quinlan et al., 2005; Bosch et al., 2007). We originally 
interpreted these structures as pre-nuclei. In contrast, Bosch (Bosch et al., 2007) proposed that 
they are stable structures that sequester actin monomers. Whether there are two paths (i.e. 
nucleation vs. SA4 complex), or one (nucleation, with formation of the nucleus from the SA4 
complex being a rate limiting step), removing capping would likely destabilize the SA4 structure 
and could favor nucleation.   
  
How do tandem-WH2-domain nucleators bind filament pointed ends? Single molecule 
observations showed that VopL/F remains associated with the pointed ends of filaments it 
nucleates for ~100 s (Burke et al., 2017). In the absence of actin monomers, VopL/F binds 
pointed ends for shorter times (~25 s). Higher affinity binding is likely due to the contribution of 
the VopL/F C-terminal domain, that dimerizes and binds the pointed end. In the case of Spir, 
weak inhibition of depolymerization may be mediated by a linker or a domain straddling the 
WH2 domains. Side binding by the C-terminal portion of tandem WH2 domains may enhance 
relatively weak pointed end binding of both Spir and VopL/F. Side binding by Spir is consistent 
with the fact that it can sever filaments (Bosch et al., 2007; Chen et al., 2012). We speculate 
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that the ability to retain the pointed ends of filaments nucleated by Spir on beads reflects 
enhanced binding due to clustering on beads (Fig. 2-7A). Multiple cases of emergent behavior 
of clustered WH2 domains have been reported. Spir nucleates more potently when clustered on 
gold particles (Ito et al., 2011). VopL retains the pointed end of ~10% of nucleated filaments for 
several minutes (compared to seconds for ~80% of filaments) and accelerates barbed end 
elongation of ~8% of filaments when clustered on Qdots (Namgoong et al., 2011); and 
Ena/VASP are potent elongation factors when clustered on beads (Breitsprecher et al., 2008; 
Winkelman et al., 2014). In sum, WH2 domains can bind both ends of actin filaments but they 
are likely to be part of a larger context which dictates their activity (Dominguez, 2016).  
  
How do Spir and Capu synergize?  
Synergy of actin assembly can be explained by enhanced nucleation and/or elongation. In the 
cases of Bud6/Bni1 and APC/mDia1, nucleation is enhanced (Graziano et al., 2011; 
Breitsprecher et al., 2012). We propose that increased nucleation is also the dominant source of 
synergy for Spir/Capu. The ping-pong model, initially proposed, suggests that Spir and Capu 
(Fmn2) enhance elongation by dynamic exchange at the barbed ends of filaments. A key 
element of the ping-pong model is that Fmn2 binds barbed ends with a slow on-rate. Thus, by 
recruiting Fmn2 to barbed ends, Spir increases the fraction of time that elongation is enhanced 
by the formin. We found that synergistic assembly of profilin-actin is actually improved in the 
absence of Spir binding to barbed ends (CapuCT+SpirNT(A*)). We also directly observed 
increased nucleation in bead assays:  CapuCT/SpirNT-beads nucleate 6x and 10x more 
potently than SpirNT-beads, with or without a functional WH2-A, respectively (Figs. 2-5D, 2-6C-
E). A full comparison (i.e. nucleation by SpirNT-beads and CapuCT-beads, versus 
CapuCT/SpirNT-beads) was precluded by the inactivity of CapuCT-beads, regardless of the 
coupling method. Finally, we see a 4–fold increase in nucleation by CapuCT/SpirNT(A*)-beads 
compared to wild type CapuCT/SpirNT-beads, similar to the ~3x decrease in t1/2 in bulk assays 
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(Fig. 2-6B). Thus, we conclude that nucleation is the major source of enhanced actin assembly 
mediated by Spir/Capu synergy.   
  
Ping-ponging may still take place and contribute to mesh assembly. We observe transfer of 
Capu-bound barbed ends to Spir (Fig. 2-4B, Video 9), consistent with one half of ping-pong. 
We do not see transfer in the other direction but our bead-based assay is not well suited to 
studying this process, as we do not have excess Spir or Capu in solution (The original 
observation of ping-pong was made with all proteins in solution (Montaville et al., 2014)). 
Importantly, the intermediate phenotype we observe in flies expressing Spir(A*)-GFP (Fig. 2-1F 
and Table 2-1) could indicate that, while not necessary, ping-ponging may enhance mesh 
assembly in the oocyte. Perhaps Spir helps Capu fall off of filaments when they reach their 
target. Additionally, Spir could pass the filament to another protein that anchors it at the vesicle 
even more stably, influencing the dynamics of the mesh. It is also possible that capping serves 
an important role in vivo, independent of the processes we are studying here.   
  
The classical nucleation promoting factors (NPFs), N-Wasp and Scar, bind actin monomers and 
the Arp2/3 complex to stimulate nucleation by the Arp2/3 complex (Machesky et al., 1999; 
Welch and Mullins, 2002). Similarly, the yeast NPF, Bud6, binds an actin monomer and the 
formin Bni1 to stimulate nucleation by Bni1 (Park et al., 2015; Graziano et al., 2011; Tu et al., 
2012). In each of these cases, the NPF has negligible independent activity. In contrast, APC 
and Spir can nucleate alone, as well as synergize with a formin (Moseley et al., 2007; Okada et 
al., 2010; Quinlan et al., 2005; Montaville et al., 2014). We note that Spir’s nucleation activity, in 
the presence of profilin, correlates with synergy: in the absence of nucleation by 
SpirNT(A*B*C*D*), no synergy is observed; when nucleation is augmented, (SpirNT(A*) 
nucleation is ~3x stronger than SpirNT), synergy with Capu is also enhanced over wild type 
(~4x). These are only two data points, but they suggest that Spir’s nucleation contributes to 
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synergy, as opposed to Spir acting as a passive actin binding protein, or NPF. In fact, if 
monomer delivery were Spir’s role, one might expect SpirNT(A*) to be a weaker Capu activator 
because it has fewer functional WH2 domains. Thus, we conclude that Spir and Capu 
collaborate by a mechanism similar to that proposed for APC/mDia1 – Spir nucleates seeds that 
are elongated by Capu (Fig. 2-7B).   
  
In vivo implications  
The filament orientation we observe, barbed-ends away from the bead, reflects the fact that Spir 
is attached to the beads and Capu is bound to Spir in our assays. As we and others have 
shown, when a formin is bound to a bead, filaments grow with their barbed ends at the bead 
surface. Both mSpire and Fmn-2 are enriched on Rab-11 vesicles. We speculate that Fmn2 is 
affiliated by binding mSpire as opposed to an independent association with the vesicle. We 
base this on the finding that mSpire binds directly to membranes and the fact that, in flies, GFP-
Capu is diffuse throughout the oocyte (Tittel et al., 2015; Quinlan, 2013). If we are correct, then 
the geometry in our assays mimics the situation in vivo and indicates that the actin filaments are 
oriented opposite to what was originally proposed by others (Schuh, 2011; Montaville et al., 
2014). Long distance transport is still possible with this orientation of filaments (Fig. 2-7C). 
Instead of myosin V capturing filaments from a neighboring vesicle, Spir or another protein 
could capture a growing filament and myosin V on the vesicle from which the filament originated 
could walk along the filament pulling the vesicle towards its neighbor (Fig. 2-7C’). In this case, 
pointed end attachment would not have to be as long lasting as barbed end retention. These 
conditions are surprisingly well satisfied in our simplified system.  
  
Increased Capu expression is sufficient to build a mesh in the absence of Spir or in the absence 
of direct interaction with Spir (Dahlgaard et al., 2007; Quinlan, 2013). In these cases, the mesh 
is not as dense or as long lived. No mesh is built when exogenous Spir expression is driven in 
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the absence of Capu (Dahlgaard et al., 2007). Thus we propose that Spir’s primary role is to 
enhance Capu’s actin assembly activity in vivo. The fact that Spir(A*)-GFP expression partially 
rescues loss of Spir indicates that barbed-end binding by Spir is not necessary. We note, 
however, that actin nucleation is enhanced, which could compensate for loss of ping-ponging or 
other barbed end binding roles of Spir. Why do formins need NPFs? In addition to adding 
another level of control in the cell, nucleation by many formins is dampened by profilin. In the 
case of the fly oocyte, we also note that the cytoplasm is enriched with microtubules which 
potently inhibit Capu by binding to its tail, where the Spir-KIND domain also binds (Roth-
Johnson et al., 2014). Thus Spir is well suited to simultaneously protect Capu from inhibitory 
factors and amplify its activity. 
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Figure 2-7 – Model of Spir—Capu synergy 
 
(A) Spir is directed to vesicles through its phospholipid-binding mFYVE domain (green helix). The 
clustering of Spir on vesicles may enhance its affinity for filament pointed-ends. Each of Spir’s tandem, 
WH2 domains (light blue) can bind to an actin subunit (dark gray spheres). (B) Spir and Capu interact 
through their respective KIND (purple) and tail (yellow) domains. (B’) Spir retains a filament’s pointed end 
(dark gray), while Capu separates from Spir to elongate its barbed end (light gray). (C) A filament’s 
barbed end is captured and capped by Spir’s WH2-A domain (light blue), displacing Capu. Spir’s bipolar 
filament binding may tether vesicles, as shown. (C’) Associated with Rab11 (pink) and Spir on vesicles, 
MyoV (dark blue) may tow a nucleating vesicle (left) toward another, receiving (filament capturing) vesicle 
(right). 
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Materials and Methods  
DNA constructs  
CapuCT (aa 467-1059) constructs were expressed from a modified pET15b vector with an N-
terminal hexahistidine tag (Vizcarra et al., 2011). All other proteins were expressed from a 
modified pET20b(+) vector with no affinity tag. A native poly-histidine region within the Spir-
KIND domain is sufficient for binding of these constructs to TALON® resin (Clontech). Gibson 
cloning was employed for the scar-free introduction of Avidity’s 45 bp Avitag™ (translated 
sequence: GLNDIFEAQKIEWHE) to all proteins requiring biotinylation for bead-conjugation. 
This tag was introduced to the C-terminus of all constructs.  
  
Expression, purification, and biotinylation of proteins  
Actin was purified from Acanthamoeba castellani as described (Zuchero, 2007) and stored in G-
buffer (2 mM Tris-Cl, pH 8.0, 0.1 mM CaCl2, 0.2 mM ATP, 0.5 mM TCEP, 0.04% sodium azide). 
Expression was induced in Rosetta™(DE3) cells (EMD Biosciences). Bacteria were grown in 
Terrific Broth medium supplemented with 100 mg⁄L ampicillin and 32 mg⁄L chloramphenicol. 
Cells were grown to an OD of 0.6 at 37°C, cooled to 18°C for 1 hour, induced with 250 μM 
IPTG, and shaken for 18 hours at 18°C. Bacteria were harvested by centrifugation. Pellets were 
washed once with ice-cold PBS, flash-frozen in liquid nitrogen, and stored at −80°C.  
  
All purification steps were carried out at 4°C or on ice. Thawed cells were diluted at least two-
fold with lysis buffer (50 mM sodium phosphate pH 8.0, 1 mM β-ME, 300 mM NaCl) 
supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF) and 2 μg⁄mL DNaseI and then 
lysed by microfluidizing, 2-3x. Cell debris was removed by centrifugation at 20,000×g for 20min 
at 4°C. Clarified lysates were then rocked with TALON® resin for 1 hour at 4°C (4 mL slurry for 
every 1 L culture pellet). The TALON® resin was washed with 20 column volumes of lysis 
buffer, followed by washing with 20 column volumes of wash buffer (lysis buffer, at pH 7.0). 
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Proteins were eluted with elution buffer (wash buffer, plus 200 mM imidazole), until little or no 
protein remained on the column, as determined by a Coomassie-stained dot-blot of the eluates.  
  
TALON® eluates were pooled and dialyzed 2 x 2 hours and once overnight against 1 L volumes 
of 10 mM Tris, 1 mM DTT, pH 8.0; or, 5 mL of the most concentrated eluates were buffer 
exchanged into the same, using a PD-10 desalting column (GE Life Sciences). Protein was 
loaded onto a MonoQ anion exchange column (GE Life Sciences) and eluted using a gradient of 
50–500 mM KCl over 60 column volumes for Spir-KIND, 50–250 mM KCl over 100 column 
volumes for CapuCT, or 0–500 mM KCl over 60 column volumes for SpirNT. Pooled fractions 
from the MonoQ column were again dialyzed or buffer exchanged as described above. Unless 
tagged with an Avitag™, 50% glycerol was added to the overnight dialysis step (1:1 
glycerol:buffer). The protein was flash-frozen in liquid nitrogen in 10-50 μL aliquots and stored at 
-80°C.  
  
If tagged with an Avitag™, 2 mL of the protein was added to 223 μL Biomix B and 5 μL (5 μg) 
BirA (both from Avidity) and rocked overnight at 4°C. The reaction was again loaded onto a 
MonoQ anion exchange column and eluted as described above. Pooled fractions from the 
MonoQ column were dialyzed or buffer exchanged as described above, with 50% glycerol 
added to the overnight dialysis step and flash-frozen in liquid nitrogen.   
  
Spir-KIND, SpirNT, and CapuCT concentrations were calculated based on their absorbances at 
280nm (ε280 = 17,452 cm−1M−1 for KIND, 25,575 cm−1M−1 for Spir-NT, and 75,200 cm−1M−1 for 
Capu-CT) (Quinlan et al., 2007).  
  
Purified VopL and mDia1-CT proteins were generously provided by the Kovar lab (U Chicago). 
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Pyrene actin assembly assays  
Bulk actin assembly assays were carried out essentially as described (Zuchero, 2007). Briefly, 
actin (5% pyrene labeled) was incubated for 2 min at 25°C with 200 μM EGTA and 50 μM MgCl2 
to convert Ca-actin to Mg-actin. When included in the experiment, Schizosaccharomyces 
pombe profilin (typically 2:1 profilin:actin) was incubated with actin for 2 min at 25°C before 
conversion to Mg-actin. Polymerization was initiated by adding polymerization buffer (KMEH, 
final concentration: 10 mM HEPES, pH 7.0, 1 mM EGTA, 50 mM KCl, 1 mM MgCl2) to the Mg-
actin. Additional components, such as CapuCT, SpirNT, and capping protein were combined in 
the polymerization buffer before addition to Mg-actin. Fluorescence was monitored in a TECAN 
F200 with λex = 360 ± 17 nm and λem = 400 ± 10 nm.  
  
Actin seeds were prepared by polymerizing 5 μM actin at 25°C for 1 hour in KMEH. The 
filaments were dispensed in 5 μL aliquots and allowed to re-equilibrate for 2–3 hours at 25°C. 
SpirNT was incubated with filaments for 3 min at 25°C. During this incubation time, monomeric 
actin was converted to Mg-actin. Using a cut pipette tip to prevent shearing, polymerization 
buffer was added to Mg-actin and then mixed with seeds plus SpirNT. The slope of the pyrene 
fluorescence trace between 200 and 500 s was considered the elongation rate.  
  
TIRF microscopy assays  
Coverslips were prepared and functionalized with polyethylene glycol (final surface composition, 
97% methoxy-PEG and 3% biotin-PEG; JenKem Technology, Allen, TX) as previously 
described (Bor et al., 2012). Biotinylated coverslips were stored in a sealed container at 4°C for 
up to 2 months before use. Flow cells with volumes of 10–15 μl were assembled using thin 
strips of double-stick tape. Streptavidin-coated microspheres were either colorless or Flash Red 
fluorescent, with mean diameters of ~100 nm or ~1 μm (Bangs Laboratories), respectively. 
Spheres were washed 2x with ~20 volumes of KMEH, resuspended in 1 volume of KMEH + 1 
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mg/mL BSA, and added in 10 μL aliquots to 40 μL pre-mixed protein mixtures in KMEH. After a 
10 min incubation on ice, spheres were spun for 10 min at 10,000x RPM and 4°C. Pellets were 
gently resuspended in 30 μL KMEH. Pellets were briefly sonicated (~5 s) if clumped and not 
well dispersed when visualized by TIRF microscopy.  
  
All buffers were flowed into cells in 25 μL volumes in the following order: 1) blocking buffer (1x 
PBS, pH 8.0, 1% pluronic, 0.1 mg/mL casein) with 2 min incubation; 2) TIRF buffer (50 mM KCl, 
1 mM MgCl2, 1 mM EGTA, 10 mM HEPES, pH 7.0, 0.2 mM ATP, 50 mM DTT, 0.2% 
methylcellulose, 20 mM glucose); 3) beads (5 μL resuspended beads, 25 μL TIRF buffer) with 2 
min incubation; 4) TIRF buffer; 5) TIRF buffer, supplemented with GCC mix (0.25 mg/mL 
glucose oxidase, 0.05 mg/mL catalase, 0.8 mg/mL casein), actin (typically 1 μM, 20% Oregon 
Green labeled), and profilin and/or capping protein, when appropriate. In this final step, actin 
and profilin (when present) were mixed and incubated for 1 min, then added to the other buffer 
components immediately before being flowed into the cell.  
  
Time zero was defined as the moment the final 25 uL mix, including actin, was entirely added. 
Polymerization was visualized immediately (typically, t = ~30 s) on a DMI6000B TIRF 
microscope (Leica, Wetzlar, Germany), controlled by LAS X (Leica software). Images were 
acquired with a DU897 EMCCD camera (Andor) and 100x/1.47 HCX PL APO objective (Leica) 
at ~25°C. All analyses were performed on raw data in FIJI. The brightness and contrast of figure 
images were minimally adjusted for clarity of image features. Filament lengths, elongation rates, 
and kymographs were analyzed/prepared with JFilament incorporated in FIJI (Smith et al., 
2010). Plots were made and statistical analyses conducted in Kaleidagraph. Filament dwell 
times were obtained by manually tracking individual, retained filaments until clearly released 
from a bead. Some filaments did not become clearly visible in the TIRF plane until some growth 
had already occurred. In these cases, time was added to the measured retention period, 
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proportional to the initial length of the filament and the average filament elongation rate 
observed in the experiment.  
  
For 2-color experiments, 1 μM Cy3B-labeled actin was introduced to the functionalized, bead-
bound flow cell. Following this (step 5 of the aforementioned protocol), and after allowing beads 
to briefly (1–2 mins) polymerize the Cy3B-actin, the following components were flowed in: 6) 
TIRF buffer supplemented with 1 μM phalloidin, with 2 min incubation; 7) TIRF buffer 
supplemented with GCC mix, 600 nM 20% labeled OG-actin, and 300 nM profilin. 
Polymerization was visualized as described above.  
  
For the plots generated in Fig. 6D/E, circles of 10 and 11 px radii (1.6 and 1.76 μm, 
respectively) were drawn around the centroids of each bead. Actin fluorescence was measured 
within these circles over time. The integrated density measurements of the 10 px circles were 
subtracted from those of their concentric, 11 px circles, to measure 1 px-wide (160 nm) bands of 
actin fluorescence, 1.6 μm away from beads. A script that performs these operations in FIJI is 
available upon request.  
  
Fluorescence measurements in Fig. 6D/E are expressed as a fraction of their initial values (i.e. 
a 10% increase = 1.1). Discrepancies in initial fluorescence values for different bead types were 
observed, in part, due to real differences in assembly rates, because actin polymerization could 
not be observed instantly. To scale these differences in assembly prior to image collection, the 
average starting values of each bead type were compared. The larger ratio of these two values 
was used as a multiplier for the more active bead type. For example, if measurements of 
SpirNT(A*)- and SpirNT-beads were 110% their initial values, these quantities would each be 
plotted as “1.1.” However, if the average, initial values of SpirNT(A*)-beads were twice those of 
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SpirNT-beads, the quantities would be plotted as “2.2” and “1.1,” respectively, reflecting the 2-
fold greater assembly by SpirNT(A*)-beads prior to image collection.  
  
Drosophila stocks  
The following stocks were obtained from the Bloomington Drosophila Stock Center (NIH 
P40OD018537): spir1 and capu1 (Manseau and Schüpbach, 1989); Df(2L)Exel6046 (Exelixis); 
and nos-GAL4-vp16 (Van Doren et al., 1998). Mutant SpirB-GFP transgenes were generated by 
inserting the coding region of spir (CG10076-RB) with point mutations created by QuikChange 
mutagenesis, between the KpnI and SpeI sites of pTIGER (Ferguson et al., 2012) with mEGFP 
inserted between the BamHI and XbaI sites. pTIGER plasmids were integrated at the attP2 
landing site by BestGene.  
  
Fertility assays  
Approximately 100 test females were crossed to 40 wild-type males and kept on apple plates for 
2 nights at 25°C. Flies were pre-cleared on a fresh plate with yeast paste for at least 1.5 hours, 
the plate was changed and eggs laid over the next 3 hours were collected. Typically, 100 eggs 
were laid in this time period. Eggs were transferred to a fresh plate and stored at 25°C. The 
number of eggs that hatched after 24 hours was recorded. Each trial was repeated at least three 
times with independent crosses.  
  
Fly oocyte microscopy and staining  
The visualization of cytoplasmic flows and the actin mesh were performed on a Leica SPE I 
inverted confocal microscope. Flies were kept at 25°C and fed yeast paste for ~24 hours before 
an experiment. Flows were visualized by imaging autofluorescent yolk granules of egg 
chambers teased apart in Halocarbon oil 700. The actin mesh was stained as described by 
Dahlgaard et al. (Dahlgaard et al., 2007) with modifications. Briefly, ovaries were dissected, 
53 
 
teased apart and fixed in 10% paraformaldehyde/PBS (pH 7.4) for a total of less than 20 
minutes. Samples were stained with 1 μM AlexaFluor488-phalloidin diluted in 0.3% Triton X-
100/PBS for 25 minutes at room temperature. Samples were then washed extensively and 
mounted in ProLong Gold with DAPI. Images were recorded within 24 hours of staining because 
phalloidin staining quality degraded over time, as has been reported (Dahlgaard et al., 2007).   
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Figure 2-8 – Supplementary data 
 
(A) SpirNT(A*B*C*D*) does not assemble actin. (B) SpirNT(A*B*C*D*) does not synergize with CapuCT 
to assemble actin. (C) SpirNT(A*) is a superior actin nucleator and does not sequester actin like wild-type 
SpirNT. (D) SpirNT(A*) demonstrates enhanced synergy/actin assembly with CapuCT and does not 
sequester actin like wild-type SpirNT. (E) A Capu-binding mutant, SpirNT(Y232K), does not synergize 
with CapuCT to assemble actin. (F) Spir-KIND/CapuCT-beads do not assemble actin or bind actin 
filaments. (G) Retention of nucleated filaments by SpirNT-beads is not dependent on the presence of 
CapuCT or profilin. Fiducial marks (bright, horizontal lines) in the kymograph are not displaced as the 
filament elongates, indicating growth away from the bead. See also, Video 7. 
 
  
60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Unique domain functions in Spire—Cappuccino 
synergy 
  
61 
 
Introduction 
Nucleation vs. capping: what are they good for? 
As noted in Chapter 1, a long-standing point of contention in the cytoskeleton field has been the 
question of which end of the actin filament Spir binds. Early evidence showed a weak (μM) 
interaction with pointed ends (Fig. 1-4) (Quinlan et al. 2005), while subsequent work with 
mammalian Spir-1 showed a stronger (nM) interaction with barbed ends (Ito et al. 2011; 
Montaville et al. 2014). The distinction of which filament end Spir interacts with is crucial, as the 
models describing synergy with Capu conflict on this detail: Ping-pong occurs at barbed ends, 
while Hand-off occurs at pointed ends. 
 
The data presented in Chapter 2 satisfyingly show that Spir can bind both ends of the filament, 
at least when Spir is clustered on a bead. With this geometry, a primary tenet of each model 
was observed – Spir handing nucleated filaments to Capu, and Spir displacing Capu from 
growing filaments. However, the core and more difficult-to-test discrepancy between the two 
models lies in the actual Spir function purportedly driving synergy: nucleation (Hand-off) or 
capping (Ping-pong) of filaments. Because nucleation by SpirNT-beads was greatly enhanced in 
the presence of Capu, the data from Chapter 2 make a strong argument for nucleation driving 
synergy (Fig. 2-6C-E). 
 
In Chapter 2, the mutant SpirNT(A*) was also introduced, whose capping function is lost and 
whose nucleation function is augmented. This mutant demonstrated enhanced nucleation and 
synergy with Capu on beads, further supporting the role of nucleation by Spir as the driver of 
synergy (Fig. 2-6C-E). However, our understanding is incomplete. In the fly, rescue by Spir(A*)-
GFP was less than 70% as efficient as its wild-type counterpart, suggesting that capping may 
still be important in vivo (Table 2-1). Furthermore, forthcoming data from Spir(D*)-GFP 
experiments in the Quinlan lab suggest that rescue by this mutant is significantly better than 
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Spir(A*)-GFP (data not shown). Because a non-functional fourth WH2 domain (D*) has been 
shown to dramatically decrease Spir’s nucleation activity (Quinlan et al. 2005), efficient rescue 
by Spir(D*)-GFP introduces the possibility that Spir nucleation is not essential for synergy in 
vivo, either. 
 
Discrepancies in Spir activity 
At least one WH2 domain is necessary for Spir to assemble actin and synergize with Capu (Fig. 
2-8A,B). Although the fly data are not yet fully understood, the WH2-A and WH2-D Spir mutants 
have proven to be excellent tools for disentangling Spir’s nucleation and capping activities. Do 
mutants of the remaining WH2 domains – B and C – offer further modulation of these activities? 
In fact, mutations which disrupt actin binding were generated and tested for each of the four 
WH2 domains when Dr. Quinlan first published on Spir. At this time, SpirNT(A*) demonstrated 
only a moderate increase in actin assembly, while assembly by SpirNT(B*) and SpirNT(C*) was 
moderately diminished (Fig. 3-1) (Quinlan et al. 2005). When we revisited the SpirNT(A*) 
mutant and observed a more dramatic increase in assembly (Fig. 2-5C), we noted that the 
difference might be attributed to a truncation of 
the protein. 
 
Dr. Quinlan’s experiments were performed with 
SpirNT(1-520), while those presented in Chapter 
2 were performed with SpirNT(1-490). Thus, we 
hypothesized that the 30-amino acid stretch 
following 490aa was involved in inhibiting actin 
assembly by Spir and/or synergy with Capu. 
Notably, recent and intriguing data in the Quinlan 
lab have also identified these residues to be 
Figure 3-1 – Nucleation by SpirNT and 
WH2 mutants 
 
From Quinlan 2005. Actin-binding mutations within 
each of Spir’s four WH2 domains have different 
effects on nucleation by SpirNT (here, (NT)Spir)  
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necessary for Myosin V (MyoV) binding. If the presence of Spir residues 490-520aa does, in 
fact, hamper actin assembly, then this domain presents another potential avenue for Spir, Capu, 
and mesh regulation. Preliminary insights into the role of these amino acids in actin assembly 
are presented in the results that follow. 
 
Clustering hypothesis 
In addition to discrepancies in the pyrene-actin assembly assay, we noted that the surprising 
association of filament pointed ends with SpirNT-beads (Chapter 2) happened reliably and 
often. Because Spir’s affinity for pointed ends was previously demonstrated to be very weak 
with Spir free in solution (Quinlan et al. 2005), we speculated that clustering on beads and/or 
dimerization of Spir strengthens its interaction with pointed ends. When we conjugated a 
dimeric, GST-tagged fusion of SpirNT to beads, no increase in nucleation or filament retention 
was apparent (data not shown). Because nucleation by GST-SpirNT is markedly increased in 
the pyrene assay and closely mimics synergistic assembly by SpirNT and CapuCT in the 
conditions tested (Vizcarra et al. 2011), we hypothesized that the clustering of Spir on beads (or 
membranes, in vivo) mimics the dimerization of Spir, making it a better nucleator and enhancing 
Spir’s affinity for filament ends – that is, its ability to retain and capture filaments. 
 
Although SpirNT(A*) is unable to cap barbed ends in vitro (Rasson et al. 2015), we noted that 
SpirNT(A*)-beads were capable of capturing – albeit very rarely – the barbed ends of filaments 
in TIRF-M. Furthermore, while SpirNT(D*) could not nucleate in pyrene-actin assembly assays 
(Quinlan et al. 2005), pilot experiments suggested that it was not entirely inactive when 
conjugated to beads (Fig. 3-2). SpirNT(D*)-beads observed were also capable of retaining the 
few filaments they nucleated. If clustering increases Spir’s affinity for either end of the filament, 
we suspected that tuning the density of Spir on beads would measurably affect these 
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interaction(s). In this chapter, we present 
preliminary data testing the clustering 
hypothesis by examining the effect of diluting 
SpirNT (wild type, A*, and D*) on beads. 
 
Capu’s role in synergy  
A significant increase in filament assembly by 
SpirNT-beads is observed when CapuCT is 
added (Fig. 2-6C-E), similar to the synergistic 
effect observed in pyrene assays (Fig. 2-6A,B). 
We showed in Chapter 2 that this synergy in 
actin assembly scales with the nucleation 
potency of Spir. Next, we asked how Capu might 
reciprocally be enhancing Spir.  
 
An existing asset of the Quinlan lab, the CapuCT(I706A) mutant bears a canonical, “formin-
killing” FH2 domain mutation (Xu et al. 2004). This mutation was previously verified to abolish 
nucleation by CapuCT while still enhancing SpirNT’s activity in vitro, presumably by increasing 
the rate of SpirNT nucleation via dimerization (Quinlan et al. 2007). However, this enhancement 
is not sufficient in vivo, based on the observation that Capu(I706A) fails to rescue the mesh 
defect in capu null flies (Quinlan 2013). These observations are consistent with the hypothesis 
that dimerization of Spir by Capu increases nucleation but is not as important an activity in vivo 
due to the already clustered geometry of Spir. Thus, the enhancement of actin assembly by 
SpirNT-beads seen in the presence of CapuCT(I706A) makes this mutant an attractive tool to 
further probe the role(s) of Capu in synergy – in addition to nucleation and the dimerization of 
Spir. We study the activities of the CapuCT(I706A) mutant in greater detail in this chapter. 
Figure 3-2 – Nucleation by SpirNT-beads is 
affected by mutations to WH2 domains 
 
(Top Row) SpirNT-beads nucleate actin. (Middle 
Row) SpirNT(A*)-beads have enhanced nucleation. 
(Bottom Row) SpirNT(D*)-beads have diminished 
nucleation. Images for each row were acquired at 1’ 
(Left Column), 5’ (Center Column) and 10’ (Right 
Column) following the introduction of G-actin. Scale 
bar = 10 μm 
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Results 
Residues 490-520 inhibit nucleation by SpirNT 
We observed that SpirNT(A*) was much more active than initially reported and hypothesized 
that this was due to the use of different truncations of Spir. Before testing for similar 
discrepancies in the remaining WH2 domain mutants, we addressed the question of whether or 
not the discrepant amino acids (490-520) impact the activity of wild type Spir. Comparing the 
two truncations in the pyrene assay, we found the presence of this 30-amino acid stretch to be 
meaningful. Plotting the half time to reach maximal F-actin signal (t1/2) at various concentrations 
of SpirNT, we observed that SpirNT(1-490) is a stronger nucleator than SpirNT(1-520) (Fig. 3-
3). 
 
Next, we asked if the presence of residues 490-520 also alters the activity of WH2 mutants. 
Having already observed the surprising increase in assembly by SpirNT(A*) relative to the 
activity reported in 2005, we interrogated the effect of mutations within the second and third 
WH2 domains, SpirNT(B*) and SpirNT(C*). 
 
A non-functional WH2-B enhances nucleation by SpirNT(1-490) 
We found that a non-functional WH2-B domain improves nucleation by SpirNT(1-490) in a 
manner similar to SpirNT(A*) (Fig. 3-4). At this point, it was unsurprising that the absence of 
490-520aa enhanced actin assembly by SpirNT(B*). However, these data curiously contrasted 
with the slight inhibition of actin assembly, relative to wild type, originally reported for this mutant 
(Fig. 3-1) (Quinlan et al. 2005). We proceeded to confirm that SpirNT(B*,1-490) is not only 
better than SpirNT(B*,1-520), but that it is also superior to a wild type Spir of the same length in 
a basic pyrene-actin assay (Fig. 3-5). 
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Under conditions which tested synergy with Capu, we again found that SpirNT(B*,1-490) is 
superior to its wild type counterpart (Fig. 3-6). These results further support the conclusion of 
Chapter 2, that nucleation by Spir is a major driver of synergy with Capu. However, we had 
expected SpirNT(B*) to be impaired in nucleation, which would have offered a tool to test 
whether a reduction in Spir nucleation results in a commensurate decrease in synergy. 
 
 
 
A non-functional WH2-C enhances nucleation by SpirNT(1-490)  
In search of an intermediate nucleator, we next tested the role of WH2-C in the pyrene assay. 
We found that nucleation by SpirNT(C*) was also enhanced in the absence of 490-520aa (Fig. 
3-7). While further characterization of this mutant is needed, preliminary data suggest that 
SpirNT(C*,1-490) also demonstrates enhanced synergy with CapuCT (data not shown). While 
these results again supported the conclusion that Spir nucleation drives synergy with Capu, no 
Figure 3-4 – Nucleation by SpirNT(B*,1-
490) is comparable to SpirNT(A*,1-490) 
 
SpirNT(B*,1-490) (dashed lines) assembles actin  
with a dose dependence (shades of blue) comparable 
to SpirNT(A*, 1-490) (solid lines)  
Figure 3-3 – SpirNT(1-490) is a stronger 
nucleator than SpirNT(1-520) 
 
The time to reach the half-maximal polymerization 
(t1/2) of actin by SpirNT(1-490) (open circles; S.D. 
shown in blue) is increased by the presence of 490-
520aa (closed circles; S.D. shown in red). 
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WH2 domains remained to mutate in search of an impaired nucleator. Thus, a strategic 
combination of WH2 mutants will be required, as noted in the discussion that later follows. 
 
 
Spir clustering may be important for nucleation, retention, and capture 
Having determined that the mutation of WH2-A, -B, or -C consistently enhanced SpirNT(1-490) 
nucleation and synergy, we wanted to probe the effect of these mutations on two other activities 
of Spir, revealed in Chapter 2: the retention and capture of actin filaments. To test the 
hypothesis that clustering Spir enhances these functions, we endeavored to preserve the 
vesicular-like geometry of Spir on a bead while tuning its density in two different ways: 1) by 
modifying bead size, or 2) by adjusting Spir’s concentration during the bead incubation step. In 
addition to observing any effect of these changes by TIRF-M, we took a bulk measurement 
approach and conducted pulldown experiments. 
Figure 3-6 – SpirNT(B*,1-490) has stronger 
synergy with CapuCT than wild type 
SpirNT(1-490) 
 
The time to reach the half-maximal polymerization 
(t1/2) of actin by SpirNT(1-490) (open circles; S.D. 
shown in blue) in the presence of profilin, capping 
protein, and CapuCT reflects Spir—Capu synergy. 
The t1/2 is reduced (synergy is enhanced) by mutating 
WH2-B (solid circles; S.D. shown in red) 
Figure 3-5 – SpirNT(B*,1-490) is a stronger 
nucleator than wild type SpirNT(1-490) 
 
The time to reach the half-maximal polymerization 
(t1/2) of actin by SpirNT(1-490) (open circles; S.D. 
shown in blue) is reduced by mutating WH2-B (solid 
circles; S.D. shown in red) 
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Reducing the size of the bead should result in fewer possible points of conjugation to Spir. The 
experiments we performed with the smallest, commercially available streptavidin-coated 
microspheres (100 nm average diameter) resulted in the same star-like explosions of actin 
polymerization we observed with the larger spheres (1 μm average diameter). We identified an 
even smaller, intrinsically fluorescent vessel to conjugate SpirNT to: the quantum dot (Qdot). 
We found precedence for such an approach with another tandem WH2 domain nucleator, 
VopL/F. Burke et al. attached VopL and VopF to Qdots and measured their interaction at both 
ends of actin filaments (Burke et al. 2017; Vizcarra and Quinlan 2017). 
 
Unfortunately, after conjugating SpirNT to multiple Qdots of various sizes (their size scales with 
their emitted fluorescence wavelength), we found that effectively no Qdot was capable of 
polymerizing actin. In fact, too late we discovered a study that showed the reported binding 
Figure 3-8 – Qdots average only one or no 
streptavidins per dot 
 
From Lippert et al. (2016). Commercially available (Life 
Technologies), PEG-coated and streptavidin-conjugated 
Qdots fail to display even one (525-605 nm light-emitting 
variants) or more than one (655 nm and 705 nm variants; 
orange and red bars) streptavidin molecule per dot, on 
average 
Figure 3-7 – SpirNT(C*,1-490) is a stronger 
nucleator than SpirNT(C*,1-520) 
 
Dose-dependent actin assembly (shades of blue/ 
purple) by SpirNT(C*,1-490) (solid lines) is inhibited 
by the presence of 490-520aa (dashed lines). 
Notably, trace plateaus are affected equivalently, 
indicating that mutation of WH2-C and the presence/ 
absence of 490-520aa do not affect sequestration of 
actin 
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capacities of these commercial Q-dots to be woefully greater than their actual capacities (Fig. 3-
8) (Lippert et al. 2016). Despite several adhesion points being advertised for the largest dots, 
we could not observe any actin assembly when SpirNT was incubated with them, suggesting 
unsuccessful conjugation. With no early success, we turned to the strategy of dilution. 
 
If clustering enhances Spir nucleation, we expected to observe a non-linear relationship 
between Spir concentration and actin assembly. As less Spir was introduced to beads, we 
observed obvious differences in nucleation, with a particularly steep drop-off in activity for the 
first dilution (Fig 3-9). We did not closely quantify these data, as we were interested in 
interrogating the activities of retention and capture and the experiment and analysis 
methodology required significant optimization to monitor changes in more than bulk nucleation 
activity. 
 
 
 
 
To address the question of whether clustering also augments Spir’s affinity for barbed and/or 
pointed ends, we supplemented our TIRF experiments with higher throughput measurements. 
Employing the same titration approach shown in Fig. 3-9, we allowed SpirNT-beads to incubate 
briefly with either F-actin or G-actin in the tube, rather than within a flow cell on the microscope. 
Figure 3-9 – Dilution of SpirNT on beads significantly alters nucleation 
 
(Left) Beads incubated with 400 nM SpirNT nucleate large stars of actin. (Middle) Beads incubated with 200 nM 
SpirNT and 200 nM KIND demonstrate less nucleation. (Right) Beads incubated with 100 nM SpirNT and 300 nM 
KIND are even less active. Scale bars = 10 μm. All images taken at 3’ after the introduction of G-actin. 
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We then used centrifugation to pellet and wash the beads before running them on a gel to see 
how much actin they pulled down. 
 
In the context of G-actin incubation, we anticipated that any pelleted actin should be associated 
with SpirNT-beads via their nucleation and retention of pointed ends. In the case of F-actin 
incubation, we expected the enrichment of actin in the pellet to be due to the capture of barbed 
ends by SpirNT-beads. Unfortunately, several attempts at this experiment failed to produce 
consistent data. Differences in actin band intensities were subtle in the gels and often 
significantly different from one iteration to the next. This was likely due primarily to inconsistency 
in pelleting and the aspiration of supernatants (i.e. the loss of beads). Due to the limitations of 
this methodology, we obtained narrow dynamic ranges and large variances in the data – two 
undesirable traits. A more thorough discussion of the problems encountered, and their potential 
answers, later follows. 
 
Despite the methodological hurdles and noisiness of the data, some interesting results were still 
extracted. By additionally incubating SpirNT-beads with either GFP-biotin or mCherry-biotin, I 
was able to account for the loss of beads during pelleting steps to some extent. Using the 
abundance of GFP or mCherry as a reference for the total beads left in the pellet at the end of 
the experiment, the data were normalized and non-linear relationships between Spir 
concentration and actin in the pellet were apparent (Figs. 3-10 and 3-11). However, the trends 
were opposite to our expectations. We observed non-linear increases in the presumed “capture” 
and “retention” activities of SpirNT as it was diluted on beads. 
 
The transformations of these data were performed simply: the concentration of actin measured 
from each pellet was multiplied by the dilution factor of SpirNT incubated with the beads. Thus, 
the relative ratios of actin:GFP plotted in Figs. 3-10 and 3-11 should be equal for all dilutions if 
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clustering has no effect on capture or retention. Instead, both the capture and retention of 
filaments are enhanced as lower concentrations of SpirNT are incubated with beads. It is 
confounding that this relationship holds true even for the WH2-A and -D mutants. SpirNT(D*)-
beads appeared expectedly less potent than SpirNT(WT/A*)-beads in the retention-testing 
pulldown experiment (which should be dependent on the nucleation of actin) (Fig. 3-11). 
However, SpirNT(A*) beads were not impaired in capture (Fig. 3-10), despite the very 
infrequent observation of this phenomenon at SpirNT(A*)-beads in TIRF-M. Taken together, 
these data suggest an interesting relationship between clustering and the functions of Spir 
studied here – nucleation, retention, and capture. Optimization of this methodology offers a 
possible means of further studying these relationships in medium-throughput. 
 
 
 
Figure 3-11 – Spir clustering may affect the 
retention of actin filaments 
 
Pulldown of bead-nucleated actin filaments via brief 
incubation of G-actin with beads conjugated to 
SpirNT(WT) (blue), SpirNT(A*) (purple), or SpirNT(D*) 
(green). 400 nM SpirNT alone, 200 nM SpirNT and 
200 nM KIND, or 100 nM SpirNT and 300 nM KIND 
(Left-to-right for each variant) were conjugated to 
beads. The data have been transformed so that the 
average number of filaments per bead (solid lines) is 
altered by dilution only if pelleted actin and SpirNT 
concentrations do not share a 1:1 relationship. 
 
Figure 3-10 – Spir clustering may affect the 
capture of actin filaments 
 
Pulldown of phalloidin-stabilized actin filaments via 
incubation with beads conjugated to SpirNT(WT) 
(blue), SpirNT(A*) (purple), or SpirNT(D*) (green). 
400 nM SpirNT alone, 200 nM SpirNT and 200 nM 
KIND, or 100 nM SpirNT and 300 nM KIND (Left-to-
right for each variant) were conjugated to beads. The 
data have been transformed so that the average 
number of filaments per bead (solid lines) is altered 
by dilution only if pelleted actin and SpirNT 
concentrations do not share a 1:1 relationship 
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CapuCT(I706A) does not nucleate but is still processive 
The Spir WH2 domain mutants have enabled us to tease out Spir’s unique contributions to 
synergy. To better understand Capu’s contribution to synergy, we turned to the CapuCT(I706A) 
mutant. CapuCT(I706A) dimerizes but is incapable of actin assembly (Quinlan 2013; Quinlan et 
al. 2007; Vizcarra et al. 2011), making it an apt tool to isolate and test the role of Spir 
dimerization by Capu in synergy. In several pilot experiments, we introduced CapuCT(I706A) to 
SpirNT-beads. Unexpectedly, we observed a synergistic increase in actin assembly (data not 
shown). If the clustering of Spir on beads mimics its dimerization, these data suggested that 
CapuCT augments the actin assembly activity of SpirNT-beads through a mechanism other than 
dimerization and/or that CapuCT(I706A) is capable of polymerizing actin. After confirming that 
this mutant had no nucleation activity in my hands in the pyrene assay (Fig. 3-12), I proceeded 
to add in the components of the synergy experiment. 
 
In the presence of profilin, synergy in assembly 
with SpirNT was evident (Fig. 3-13). We also 
observed that CapuCT(I706A) alone was 
capable of polymerizing actin in the presence of 
profilin, albeit with 25-fold weaker activity, based 
on the concentrations required to obtain specific 
activity levels (Fig. 3-14; compare with Fig. 3-
13). This result suggested that, although 
CapuCT(I706A) is essentially incapable of 
nucleation, it can still enhance the rate of 
polymerization of spontaneous/existing nuclei. In 
fact, the lag phase seen in each trace in Fig. 3-
14 is atypical for CapuCT (Bor et al. 2012; Vizcarra et al. 2011) and supports this explanation. 
Figure 3-129 – CapuCT(I706A) does not 
nucleate actin 
 
Even at 500 nM (dark blue line), CapuCT(I706A) 
alone does not stimulate actin assembly. A weaker 
nucleator than wild type CapuCT, SpirNT alone is 
also shown (green lines). 
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Thus, we hypothesized that the I706A mutation (within the FH2 domain) abolished nucleation 
but not elongation by CapuCT. To test if CapuCT(I706A) was still capable of processively 
tracking, elongating, and/or protecting barbed ends, we introduced capping protein to the 
experiment. 
 
 
  
With the same range of CapuCT(I706A) concentrations used when minimal nucleation of PA 
was observed, a small but obvious change in actin polymerization was apparent in the presence 
of 2 nM capping protein. Protection of filament capping can be inferred from the steady increase 
in F-actin signal when 200 nM or greater CapuCT(I706A) was present (Fig. 3-15). Strikingly, 
this effect was still apparent at 25-fold lower concentrations of CapuCT(I706A), and with SpirNT 
also present (Fig. 3-16). Because this effect was weak in both cases, we suspect that 
CapuCT(I706A) enables, but does not necessarily accelerate, the elongation of filaments in the 
Figure 3-14 – CapuCT(I706A) weakly 
assembles actin in the presence of profilin 
 
At high concentrations (e.g. 500 nM; dark blue line), 
CapuCT(I706A) alone can stimulate actin assembly in 
the presence of profilin. Notably, and atypical for 
CapuCT, a lag phase is observed in these conditions, 
suggesting the impairment, or absence, of nucleation. 
A poor nucleator in the presence of profilin, SpirNT 
alone is also shown (green lines). 
 
 
Figure 3-13 – CapuCT(I706A) synergizes 
with SpirNT in the presence of profilin 
 
SpirNT alone is a poor nucleator of actin in the 
presence of profilin (green lines). Actin assembly is 
increased in a dose-dependent manner by the 
addition of CapuCT(I706A) (shades of blue). 
 
 
74 
 
presence of profilin and/or capping protein. Furthermore, F-actin plateaus were quickly reached, 
suggesting that this mutant is easily displaced by capping protein and/or Spir and cannot 
reciprocally displace either protein to rebind a barbed end. Irreversible displacement by Spir is 
more likely, given the lack of plateaus observed at the same timescale, but in the absence of 
Spir (Fig. 3-15). However, the concentrations of CapuCT(I706A) used in these two experiments 
again differ 25-fold. A more careful comparison of this mutant’s behavior in each condition is 
necessary. 
 
 
 
Further supporting the aforementioned hypotheses; preliminary data from elongation assays by 
TIRF-M suggested to us that filament growth rates are unaffected by CapuCT(I706A) but that 
the mutant is likely processive and protects barbed ends from capping protein. There is now 
Figure 3-16 – CapuCT(I706A) synergizes 
with SpirNT in the presence of profilin and 
capping protein 
 
SpirNT alone does not enhance actin assembly in the 
presence of profilin and capping protein (green lines). 
Actin assembly is increased in a dose-dependent 
manner by the addition of CapuCT(I706A) (shades of 
blue). Notably, plateaus for each trace are obvious 
and suggest that CapuCT(I706A) does not efficiently 
protect barbed ends from capping protein in these 
conditions. 
Figure 3-15 – CapuCT(I706A) weakly 
assembles actin in the presence of profilin 
and capping protein 
 
At high concentrations (e.g. 500 nM; dark blue line), 
CapuCT(I706A) alone can stimulate actin assembly in 
the presence of profilin and capping protein. Notably, 
the traces do not plateau, suggesting processive 
protection and/or elongation of barbed ends by 
CapuCT. SpirNT alone does not enhance actin 
assembly in these conditions (green lines). 
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precedent for a formin with native behavior of this sort. Work in the Quinlan lab showed that the 
Fhod formin antagonizes capping protein and permits, but does not accelerate, the rate of 
filament elongation in the presence of profilin (Patel et al. 2018). In the presence of profilin and 
CapuCT(I706A), elongation rates – as measured by bulk, pyrene-actin assembly assays – are 
unaffected (Fig. 3-17). This contrasts with the acceleration of rates seen with wild type CapuCT 
(Fig. 3-18).  
 
 
When capping protein was added to these experiments, a saturating concentration of 
CapuCT(I706A) restored the average rate of growth seen in the absence of capping protein 
(Fig. 3-19) but was incapable of enhancing it, like wild type CapuCT (Fig. 3-20). These 
observations again support the hypothesis that the I706A mutation disrupts nucleation and the 
Figure 3-18 – CapuCT accelerates filament 
elongation rates in the presence of profilin 
 
The rates of increase in F-actin in a pyrene 
experiment containing seeds, a limiting concentration 
(500 nM) of G-actin, and profilin reflect the rate of 
filament elongation. This rate is consistent across 
experiments without CapuCT (black bars) and is 
increased by the addition of CapuCT, in a dose-
dependent manner (purple and blue bars). 
 
 
Figure 3-17 – CapuCT(I706A) does not 
accelerate filament elongation rates in the 
presence of profilin 
 
The rates of increase in F-actin in a pyrene 
experiment containing seeds, a limiting concentration 
(500 nM) of G-actin, and profilin reflect the rate of 
filament elongation. This rate is consistent across 
experiments without CapuCT (black bars) and is 
unchanged by the presence of even 200 nM 
CapuCT(I706A) (rightmost bar; dark red). 
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enhancement of elongation by CapuCT, but not its processivity, protection from capping protein, 
or utilization of PA. 
  
Figure 3-20 – CapuCT accelerates filament 
elongation rates in the presence of profilin 
and capping protein 
 
The rates of increase in F-actin in a pyrene 
experiment containing seeds, a limiting concentration 
(500 nM) of G-actin, and profilin reflect the rate of 
filament elongation. In the presence of 1 nM capping 
protein, effectively no elongation is observed (gray 
bar). The addition of CapuCT (purple and blue bars) 
accelerates the rate of elongation above that 
observed without capping protein present (black bar). 
 
Figure 3-19 – CapuCT(I706A) rescues 
filament elongation rates in the presence of 
profilin and capping protein 
 
The rates of increase in F-actin in a pyrene 
experiment containing seeds, a limiting concentration 
(500 nM) of G-actin, and profilin reflect the rate of 
filament elongation. In the presence of 1 nM capping 
protein, effectively no elongation is observed (gray 
bar). The presence of 400 nM CapuCT(I706A) (dark 
red bar) rescues the rate of elongation observed 
without capping protein (black bar), indicating that 
CapuCT(I706A) can protect barbed ends from 
capping protein. 
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Discussion 
The role of Spir 490-520aa 
In this chapter, we present evidence that the 30 amino acids following 490aa negatively affect 
nucleation by SpirNT. As previously noted, the same stretch of residues appears to be 
necessary for MyoV binding. Perhaps the MyoV interaction relieves this additional layer of Spir 
auto-inhibition in vivo? If this is true, Spir would be activated to nucleate more effectively – 
possibly, instead of engaging with filament barbed ends – by MyoV proximity. This situation 
could occur in vivo when MyoV coordinates the movement of one vesicle toward another (Fig 2-
7C’). 
 
Modulation of Spir nucleation can be simply tested by including MyoV or the 490-520aa peptide 
in pyrene and bead assays. In the bead experiment, the frequency of capture and retention 
events can also be measured on SpirNT-beads with and without the 490-520aa domain intact 
and/or MyoV present. Furthermore, additional, C-terminal residues may alter or intensify any 
effects observed. The results reported here for SpirNT(1-520), SpirNT(1-490), and their mutants 
differ strikingly enough to warrant comparison to the slightly longer, known isoform of Spir in 
flies, containing amino acids 1-586 (isoform “D”). 
 
WH2 mutants modulate Spir nucleation 
Mutations of WH2 domains A, B, or C variably enhance nucleation by SpirNT, whereas 
nucleation is abolished when WH2-D or all four WH2 domains are mutated. Notably, the 
fluorescence plateaus (total F-actin) in pyrene assays begin to drop when concentrations of 200 
nM or more SpirNT(B*) (not shown) or SpirNT(C*) (Fig. 3-7) are added, consistent with the 
trend observed for wild type SpirNT. This contrasts with the lack of change in plateau observed 
in similar assays with high concentrations of SpirNT(A*) (Fig. 2-8C), indicating that actin binding 
by the WH2-A domain is necessary for Spir to sequester actin. Furthermore, changes in plateau 
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are equivalent for each truncation, suggesting that the 490-520aa domain does not participate in 
this activity (e.g. Fig. 3-7). Perhaps the absence of actin binding by WH2-A discourages 
formation of the potentially sequestering, so-called SA4 complex, while WH2-B and -C mutations 
do not. Further interrogation of these domains is required to test this hypothesis. Structural data 
(i.e. X-ray crystallographic and/or EM structures) for these mutants, in complex with actin, would 
offer particularly useful insights into this story. 
 
Because mutating WH2-B, -C, or -D does not impact sequestration and/or capping but mutating 
WH2-A does, these domains offer a means of tuning Spir nucleation and of switching capping 
on and off. Various combinations of these mutants, therefore, offer more precise probing of 
which Spir functions alter synergy with Capu. This approach can be applied to in vitro pyrene 
and bead assays, as well as in vivo fertility, mesh and streaming experiments. Preliminary data 
show promise for this approach, as the combination of WH2-A and -C mutations does result in 
an intermediate nucleator which should also be incapable of capping/sequestering (Fig. 3-21). 
 
 
 
Clustering Spir may tune nucleation, retention, and capture 
In conjunction with the development and characterization of various WH2 domain mutant 
combinations, the bead assay is a powerful method to test capture and retention. However, 
Figure 3-21 – SpirNT actin assembly can 
be tuned by multiple WH2 domain mutations 
 
SpirNT(A*) (not shown) and SpirNT(C*) (orange and 
red lines) are stronger nucleators than wild type 
SpirNT (blue lines). While mutation of WH2-D (not 
shown) or all four of Spir’s WH2 domains abolishes 
nucleation (green lines), combinations can result in 
intermediate actin assembly (e.g. SpirNT(A*C*); 
purple lines). 
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measuring these phenomena by TIRF-M is a low-throughput, time-intensive approach. The 
pulldown experiments introduced in this chapter (Figs. 3-10 and 3-11) suffered from numerous 
limitations but offer an avenue to test retention and capture in higher throughput. This is 
important, given the number of experimental permutations possible if the aforementioned 
mutants, truncations, and combinations of each are to be tested. Thus, a discussion of the 
problems inherent in the pulldown method is warranted. The major sources of error in the 
capture/retention pulldown experiments, and possible answers to these problems, are detailed 
below: 
1. Inconsistent bead pelleting 
i. Importantly, the pulldown experiments presented in this chapter were performed 
with smaller, ~100nm diameter beads. These are more challenging to work with 
than the larger, ~1μm diameter beads, which pellet more quickly/easily. 
2. Inconsistent sample loading in gel 
i. This was affected by the inconsistent bead pelleting, but is also a function of 
protein remaining adhered to beads. The streptavidin-biotin interaction can 
withstand boiling temperatures. Thus, these gel samples may require additional 
treatment to better strip the beads of SpirNT and any other conjugated proteins 
(i.e. GFP/mCherry). 
3. Non-specific pulldown of actin catching on beads 
i. When performing 2-color experiments in TIRF (as in Chapter 2), longer actin 
filaments often became ensnared by beads. Often, the filaments were entangled 
by clusters of beads. If this occurs in a flow cell, it is likely to occur during 
centrifugation in a tube, as well. This problem cannot be avoided entirely, but can 
be mitigated to some extent by brief sonication of beads prior to their introduction 
to the experiment and by smartly selecting shorter incubation times with actin to 
preclude the production of very long filaments. 
4. “Sticky” GFP/mCherry 
i. Without the presence of some salt and BSA to block them, beads coated in GFP 
or, to a lesser extent, mCherry were “sticky.” The sides of filaments would often 
associate with them when visualized by TIRF-M. In fact, control beads 
(conjugated to only GFP or mCherry) consistently pulled some actin into the 
pellet in pulldown experiments, which may be due in part to this “stickiness.” 
Using intrinsically fluorescent beads or alternative fluorophores which 
demonstrate less of this “sticky” property may address this concern. 
5. Imperfect transformation of data 
i. The data for these experiments were simply multiplied by a dilution factor, with 
the assumption that biotinylated KIND domain would bind beads with kinetics 
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identical to biotinylated SpirNT. Because the KIND domain is significantly smaller 
than SpirNT, it is likely that it more quickly accesses and becomes conjugated to 
beads. Thus, we likely underestimate the density of SpirNT on beads via dilution 
in this chapter. Notably, this would mean that the trends we observed in Figs. 3-
10 and 3-11 are even farther from our expectation. Perhaps the use of KIND is 
unnecessary if the concentration of SpirNT on beads can be retroactively well 
quantified (e.g. by employing a better “bead-stripping” protocol before loading 
onto a gel). Alternatively, another inert molecule, closer to the size of SpirNT, 
could be used in place of the KIND domain. 
 
In addition to better refining the dilution and pulldown approaches, testing the role of various 
mutants and the clustering of Spir on Qdots should not be ruled out. Perhaps obtaining larger 
Qdots (ideally, better validated and endorsed by other, academic researchers) would similarly 
make the approach of “smaller beads” a more viable one to test the clustering hypothesis with, 
while offering a resolution unobtainable by pulldown but required for more detailed 
measurements (e.g. filament dwell times). 
 
CapuCT(I706A) synergy 
We studied CapuCT(I706A) and its effect in the pyrene assay under various conditions because 
we expected it to demonstrate synergy-promoting activities other than the dimerization of Spir. 
While we were rewarded with exactly that, we realized that the I706A mutation does not 
completely abolish CapuCT’s actin assembly activities. The data presented here indicate that 
CapuCT(I706A) is incapable of nucleating actin alone, but that it still synergizes with SpirNT. 
This mutant was previously reported to synergize with SpirNT. The increase in assembly by 
SpirNT seen in the presence of CapuCT(I706A) was similar to that of GST-SpirNT (Vizcarra et 
al. 2011). Thus, the increase in assembly was presumed to be caused by the dimerization of 
SpirNT, in each case. 
 
However, the observed synergy of CapuCT(I706A) with SpirNT-beads (data not shown) 
suggests that Capu’s contribution to synergy is more complex than the dimerization of Spir. It is 
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our hypothesis that Spir clustering on membranes/beads effectively dimerizes it, making Spir a 
better nucleator and increasing its affinity for both pointed and barbed ends. If this is true, 
dimerization by Capu should have little-to-no effect. Perhaps, instead, Capu enables Spir to 
utilize PA. Spir’s poor nucleation of PA is improved in the pyrene assay, and nucleation of PA by 
SpirNT-beads in pilot experiments was significantly augmented, in the presence of 
CapuCT(I706A). In this chapter, we have shown that the FH2 domain mutation, I706A, 
abolishes CapuCT nucleation and acceleration of elongation. However, the mutant remains 
processive and protects barbed ends from capping protein. Thus, excluding any effect of 
dimerization, enhancement of Spir by CapuCT(I706A) is likely mediated by the latter’s FH1 
domain. 
 
The fruit fly protein, Fhod, antagonizes capping protein and permits, but does not accelerate, 
the rate of filament elongation in the presence of profilin (Patel et al. 2018). However, this 
protein still dimerizes and nucleates. Similar to the use of WH2 domain mutations as specific 
Spir-function-altering modules, Fhod and CapuCT(I706A) offer the potential to tune specific 
Capu activities and measure their impact on synergy. Strategic hybrids of these proteins 
(Introducing CapuCT’s Spir-binding tail domain to Fhod, or replacing CapuCT’s FH2 domain 
with Fhod’s, as examples) offer unique means of both better understanding formin architecture 
and further interrogating Capu’s role in synergy. 
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Materials and methods 
DNA constructs  
CapuCT (aa 467-1059) and CapuCT(I706A) constructs were expressed from a modified 
pET15b vector with an N-terminal hexahistidine tag (Vizcarra et al., 2011). All Spir proteins were 
expressed from a modified pET20b(+) vector with no affinity tag. A native poly-histidine region 
within the Spir-KIND domain is sufficient for binding of these constructs to TALON® resin 
(Clontech). Gibson cloning was employed for the scar-free introduction of Avidity’s 45 bp 
Avitag™ (translated sequence: GLNDIFEAQKIEWHE) to all proteins requiring biotinylation for 
bead-conjugation. This tag was introduced to the C-terminus of all constructs. 
 
Spir WH2 mutants were either: previously generated, with any “scarring” later removed by 
Gibson cloning, blunt end ligation, or a similar technique; or generated by the improved 
“QuikChange” protocol (Liu & Naismith, 2008). 
  
Expression, purification, and biotinylation of proteins 
Expression, purification, and biotinylation of proteins were performed as described in Chapter 2. 
 
Pyrene actin assembly assays  
Bulk actin assembly assays were carried out as described in Chapter 2. 
 
For the seeded elongation experiments quantified in Figs. 3-17 – 3-20; Actin seeds were 
prepared by polymerizing 10 μM actin at 25°C for 1 hour in KMEH. The filaments were 
dispensed in 5 μL aliquots and allowed to re-equilibrate for 1 hour at 25°C. Using a cut pipette 
tip to prevent shearing, polymerization buffer was added to Mg-actin and then mixed with seeds 
plus CapuCT. The slope of the pyrene fluorescence trace between 200 and 500 s was 
considered the elongation rate. 
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TIRF microscopy assays 
Bead assays were performed as described in Chapter 2. For dilution experiments, beads were 
incubated with the same volume (40 μL) of pre-mixed proteins. Biotin-KIND was used to replace 
each reduction in biotin-SpirNT (e.g. 2-fold dilution of 400 nM biotin-SpirNT bead incubation = 
200 nM biotin-SpirNT + 200 nM biotin-KIND). 
  
Capture and retention bead pulldown assays 
For the pulldown experiments quantified in Figs. 3-10 and 3-11, beads were washed, 
conjugated to SpirNT, and otherwise handled as described in Chapter 2 for the TIRF 
microscopy assays. Rather than flowing into a chamber to visualize by TIRF, the beads were 
briefly incubated with actin in a tube as follows: 
For capture experiments: 
1. Repeat pipette 10 μL of 9.09 μM F-actin (Actin/ME/KMEH) mix into each clear plate well 
2. Use a multi-channel pipette to transfer 3.7 μL 9.09 μM actin into each capture tube 
3. Wait 10 min 
4. Spin for 45 min @ 25,000 G at room temperature 
5. Aspirate off and save sups in prepared tubes 
6. Wash pellets with 200 μL KMEH(A) if solid enough or spin once more at 100,000 G for 
15 min 
7. Aspirate off sup and resuspend pellets in 34 μL of 1x KMEH + 1x sample buffer 
8. Dispense premixed buffer into each tube, sonicate ~10 s and boil ~5 min 
9. Load on a gel or freeze 
 
For retention experiments: 
1. Add 20 μL 20 μM actin to 20 μL 2x KMEH 
2. Mix a bit and repeat pipette 10 μL 10 μM actin into each clear plate well 
3. Add 3.33 μL 10 μM G-actin to each tube; spin 1-2s in microfuge 
4. Wait 10 min 
5. Spin for 45 min @ 25,000 G at room temperature 
6. Aspirate off and save sups in prepared tubes 
7. Wash pellets with 200 μL KMEH(A) if solid enough or spin once more at 100,000 G for 
15 min 
8. Aspirate off sup and resuspend pellets in 33 μL of 1x KMEH + 1x sample buffer 
9. Dispense premixed buffer into each tube, sonicate ~10 s and boil ~5 min 
10. Load on a gel or freeze 
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Chapter 4: Development of a Spire-Cappuccino FRET system 
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Introduction 
 
Spir—Capu binding is transient 
In Chapter 2, a bead-based experiment was developed to mimic the geometry seen with Spir 
localizing to Rab11-positive vesicles in the mouse oocyte (Holubcová, Howard, and Schuh 
2013; Kerkhoff et al. 2001). Early localization data in the fly also showed Spir’s association with 
the oocyte cortex and its possible enrichment on vesicles (Quinlan 2013; Quinlan et al. 2007). 
Forthcoming and higher resolution localization data in the Quinlan lab further support the pattern 
of vesicle localization. Furthermore, when artificially driven to membranes, Spir’s KIND domain 
was shown to recruit Capu in cultured cells (Quinlan et al. 2007). Genetics experiments indicate 
that this interaction is required for oogenesis (Quinlan 2013). However, Capu’s localization in 
vivo appears diffuse and distinct from Spir’s, suggesting that their interaction is transient. 
Indeed, we now know that Spir and Capu separate when synergistically assembling actin on 
beads (Fig. 2-7B,B’). 
 
FRET is a sensitive technique 
A sensitive method is required to measure when and where necessarily intermittent protein-
protein interactions occur. The Förster resonance energy transfer (FRET) phenomenon requires 
close proximity of fluorescent tags (about 40-50Å) (Akrap, Seidel, and Barisas 2010; Lleres, 
Swift, and Lamond 2007; Seth et al. 2003). Outside this range, the concomitant reduction and 
enhancement of donor and acceptor fluorophore emission intensities, respectively, does not 
occur. Thus, this technique allows for great sensitivity in detecting spatial interactions. With 
optimized tag placement, only close contacts are observed by FRET. Subtle perturbations in 
binding efficiency are measurable as a decrease in FRET efficiency. 
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There are three primary ways of measuring FRET: as a decrease in donor fluorescence, an 
increase in acceptor fluorescence, or as a decrease in the fluorescence lifetime of the donor. 
The latter is arguably the most powerful and sensitive approach but requires a unique 
microscope equipped for fluorescence lifetime imaging microscopy (FLIM). FLIM permits the 
detection of even very brief binding events. By measuring changes in FRET (by FLIM) in vivo, 
the points in space and time at which Capu and Spir interact in the oocyte can be sampled. 
These data would permit us to address the very challenging question of how Spir/Capu 
localization and interaction change throughout the development of the oocyte. 
 
Visualization of oogenesis stage transitions 
FRET is an apt technique to study changes in localization patterns (specifically, points of Spir—
Capu interaction) during the various stages of oogenesis. Of particular interest, is the transition 
of the oocyte from Stage 9 to Stage 10b/11, when mesh disappears and fast streaming begins 
(Dahlgaard et al. 2007; Quinlan et al. 2007; Theurkauf et al. 1992). The “dumping” of nurse cell 
contents into the ooplasm closely follows the onset of fast streaming and may further alter 
Spir/Capu localization/interaction patterns (Bor, Bois, and Quinlan 2015; Dahlgaard et al. 2007; 
Quinlan 2016). However; historically, visualizing Spir or Capu during these transitions has been 
impossible. Work is now being done in the Quinlan lab to develop a means of extended, live 
imaging of the ovary – and potentially individual oocytes – as recently demonstrated with the 
fruit fly midgut (Martin et al. 2018). A functional FRET system would empower this technique to 
reveal many unknown facets of Spir—Capu synergy. 
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Results 
Terminal labels fail to FRET 
Traditional C/N-terminal labeling of Spir and Capu were predicted to fail based on structural 
data (Vizcarra et al. 2011), as the termini are farther apart (>10 nm) than the Förster radii of 
suitable fluorescent protein pairs (Akrap et al. 2010). Our in vitro analyses of these existing 
fusion proteins confirmed that this was the case: no FRET was observed. Therefore, I 
developed several new placements of the Spir tag, within predicted loops in the KIND domain 
(Fig. 4-1). These placements were informed by structural data of human Spire1, combined with 
predictive algorithms which integrated the homologous Drosophila Spir sequence, via SWISS-
MODEL (Arnold et al. 2006; Biasini et al. 2014; Guex, Peitsch, and Schwede 2009; Kiefer et al. 
2009). In this manner, I was able to develop a successful FRET pair, comprised of GFP-tagged 
Spir and mCherry-tagged Capu (Fig. 4-2). 
 
SpirNT-GFP(217-218aa and 275-276aa) demonstrate FRET but also diminished synergy 
The homology structure of Spir identified a disordered loop region. Because the modeling 
software could not ascribe an obvious secondary structure to this region, and because it was 
near to – but displaced away from – the Fmn-2 binding site, we focused our initial insertions of 
the GFP tag near this region. At the bottom of the disordered loop, most distal to other 
secondary structural elements in the Spir homology model, we inserted GFP between Spir 
residues 275aa and 276aa. When this GFP-SpirNT fusion was added to mCherry-CapuCT, 
actin polymerization assays unfortunately revealed decreased activity (Fig. 4-3). These data 
suggested that one or both of the fluorescent tag(s) interfered with activity, despite some 
retention of binding affinity, as evidenced by the FRET signal. 
 
We proceeded to insert GFP into various positions in the SpirNT sequence which were near to 
its Capu-binding site (Fig 4-1; orange tyrosine residue) but not within regions predicted to be 
90 
 
within a secondary structural element. In this way, we identified an insertion point for GFP 
between SpirNT residues 217-218aa which was also capable of FRET with CapuCT-mCherry. 
This insertion is just N-terminal to the predicted α-helix which contains the Capu-binding 
tyrosine residue (Y232). Unfortunately, this insertion also impaired SpirNT’s actin assembly with 
CapuCT in the pyrene assay. 
 
 
Figure 4-1 – Successful FRET placements of GFP within Spir 
 
 
 
We suspected that our placement of GFP may have perturbed CapuCT-mCherry binding, or 
proper folding of the domains in which it was embedded or juxtaposed to. To address these 
issues, we added apposing linker sequences – as incorporated by Okreglak and Drubin for the 
ABP, cofilin – on either side of the GFP insertion (Okreglak and Drubin 2007). The addition of a 
flexible linker should help to displace a fluorophore from the domain it is inserted into and 
mitigate any interference with proper folding. 
45° x-axis 
 
Homology model of D.m Spire (blue), based on 3R7G (PDB) co-crystal of Spir1 in complex with Fmn2 (Capu 
homolog) tail (red). Green spheres highlight the residues flanking the two GFP insertion sites that give FRET 
signals but have attenuated function in pyrene assays. Gray spheres denote the four unsuccessful insertion sites 
tried. The conserved tyrosine residue, necessary for Spir’s ability to bind Capu, is shown in orange, as well as its 
complementary binding surface on the Fmn2 tail helix. The dark red sphere denotes the C-terminus of Fmn2 tail, 
where Capu is labeled with mCherry. The two-residue surface highlighted in yellow indicates the C-terminus of the 
solved Spir1 crystal structure. The residues C-terminal to this yellow patch (including the 275aa site), therefore, 
fall within extended regions of disorder in the structure, due to uncertainty in modeling. 
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Unfortunately, the addition of linkers abolished FRET for both 217-218aa and 275-276aa 
insertions and failed to improve synergy as measured by pyrene assays. Furthermore, the 
addition of linkers failed to enable FRET for any of the other GFP insertions they were 
incorporated for (Table 4-1). Despite their reduced activity in biochemical assays, we intended 
to introduce the constructs with successful FRET to the fly to see if the phenomenon could still 
be observed in vivo. However, after consultation with multiple fluorescence microscopy experts, 
it was determined that the degree of FRET observed (Fig. 4-2) was insufficient to measure in an 
in vivo setting. Additionally, I observed that low concentrations of Capu-mCherry could actually 
increase the light emission of Spir-GFP constructs, while higher concentrations would decrease 
it. Further confounding, the binding of untagged, control CapuCT to GFP-tagged Spir constructs 
sometimes altered the fluorescence emission of GFP, precluding meaningful measurements of 
FRET in vitro. 
Figure 4-3 – GFP-SpirNT is impaired in 
synergistic actin assembly with CapuCT 
 
In the presence of 4 μM profilin and 2 nM capping 
protein, spontaneous assembly of 2 μM actin is 
suppressed (black line). Actin assembly by GFP-
SpirNT and CapuCT (green line) is inhibited 
relative to wild type SpirNT and CapuCT (blue 
line). Here, GFP-SpirNT(275-276aa) is used but 
the result is similar for GFP-SpirNT(217-218aa) 
Figure 4-2 – Emission spectra of GFP-
SpirNT(275-276aa) and CapuCT-
mCherry 
 
Emission spectra at excitation, λ = 475nm. In the 
presence of mCherry (yellow line), the 
fluorescence emission of the GFP tag (green line) 
within Spir’s KIND domain is reduced (solid 
triangle), while mCherry’s emission (purple line) is 
correspondingly increased (open triangle), 
indicating FRET. 
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GFP Placement in 
SpirNT (aa) 
Pyrene Assembly 
Alone Like WT 
Pyrene Synergy with 
CapuCT Like WT 
FRET 
100-101 R ND No 
129-130 Yes Yes No 
138-139 Yes Yes No 
138-139+La ND ND No 
217-218 Yes R Yesb 
217-218+La Yes R No 
238-239 Yes Yes No 
262-263 R R No 
262-263+La R R No 
275-276 Yes R Yesb 
275-276+La Yes R No 
 
R, reduced. ND, not determined. 
a L, linker. On both sides of the GFP sequence, the following 12-amino acid linker was added: 
GHGTGSTGSGSS 
b As noted in the text, successful FRET pairs still failed to FRET during some experimental repeats and at 
concentrations that deviated significantly from a 1:2 ratio of GFP-SpirNT:CapuCT-mCherry 
  
Table 4-2 – Locations of GFP insertion within SpirNT 
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Discussion 
FRET by Spir and Capu is a high-risk, high-reward opportunity 
FRET would be a very valuable tool for probing the Spir—Capu interaction. By measuring 
changes in FRET (by FLIM) in vivo, the challenging question of how Spir/Capu localization and 
interaction change throughout the development of the oocyte can be addressed. A FRET pair 
would also be a very useful tool for screening candidates in vitro for interaction with Spir/Capu. 
 
In addition to their FH1 and FH2 domains, formins typically also bear domains which bind to and 
inhibit one another. Capu and its homologues do not have canonical, diaphanous inhibitory 
domains (DID) or diaphanous autoregulatory domains (DAD). However, the presence of Capu’s 
inhibitory and autoregulatory domains (CID and CAD) permit a similar interaction to occur which 
may prevent nucleation in vivo without activation of some sort (Bor et al. 2012). A direct 
interaction between Spir and Capu is required for their function,Error! Bookmark not defined. 
and the N-terminal Spir-KIND domain binds the C-terminal Capu-tail with ~100 nM affinity, 
which should effectively outcompete the tail’s interaction with Capu’s inhibitory domain (CID) 
(Bor et al. 2012; Quinlan 2013). However, our understanding of the functional consequences of 
this interaction remain incomplete. 
 
Additionally, doubly tagging either Spir, Capu, or both, near regions with known or putative 
autoinhibitory roles (e.g. KIND or 490-520aa, respectively) would allow for the measurement of 
FRET in regions where they are inactive. Capu is a good candidate for this approach because 
its autoinhibitory domains are spaced far from one another. A high FRET signal would 
demarcate where Capu is autoinhibited and a loss of FRET, where Capu is activated. Spir is 
also a potential candidate for this approach, as it is autoinhibited by the interaction of its termini 
(Tittel et al. 2015) and we now have evidence of an inhibitory interaction with residues 490-520 
(Chapter 3). 
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It’s very surprising that the C-terminal, mCherry tag didn’t disrupt Capu’s activity. It’s possible 
that this placement, and not that of Spir’s GFP, is the real problem inhibiting synergy in our in 
vitro tests of activity, but that the issue only occurs in the presence of Spir and/or GFP. GFP and 
mCherry can be “sticky” proteins, as I observed when conjugating them to beads. This property 
could contribute to the undesirable loss of activity seen for several of the Table 4-1 mutants in 
pyrene assays. Perhaps alternative fluorophores could be installed in the same positions as for 
the successful FRET pairs shown in Table 4-1, or the insertion of mCherry can be made 
somewhere else within CapuCT to better preserve folding/function. The development of an 
extended live-imaging technique in the Quinlan lab would imbue a Spir—Capu FRET pair with 
significant power/value. Despite the challenges presented here, further investment in developing 
this FRET system is therefore warranted. 
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Materials and Methods 
DNA constructs  
CapuCT-mCherry was expressed from a modified pET15b vector with an N-terminal 
hexahistidine tag (Vizcarra et al., 2011). All GFP-SpirNT proteins were expressed from a 
modified pET20b(+) vector with no affinity tag. A native poly-histidine region within the Spir-
KIND domain is sufficient for binding of these constructs to TALON® resin (Clontech). Gibson 
cloning was employed for the scar-free introduction of mEGFP to each of the insertion sites 
indicated in Table 4-1. 
 
When linkers were added, they were first introduced by Gibson cloning to: 1) Either side of the 
insertion site within SpirNT, with 10-20 additional bases, each, complementary to the N- and C-
terminal mEGFP sequences; or 2) The N- and C-termini of mEGFP, with 10-20 additional 
bases, each, complementary to either side of the insertion site within SpirNT. The mEGFP – 
with or without linkers – was amplified by PCR and the SpirNT::pET20b template was linearized 
from the GFP-insertion site in a separate amplification reaction. The two fragments were then 
combined by Gibson assembly. 
 
Expression, purification, and biotinylation of proteins 
Expression, purification, and biotinylation of proteins were performed as described in Chapter 2. 
 
Pyrene Assays 
Pyrene assays were performed as described in Chapter 2 with the conditions indicated in Fig. 4-
3. 
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In vitro FRET tests 
Proteins were mixed or not in cold, 1x KMEH. Protein solutions were then added to a cold 
cuvette, and excited at λ = 475 nm at room temperature using a PTI fluorometer (Photon 
Technologies International, Lawrenceville, NJ). Emission spectra from λ = 480 nm – 700 nm 
were obtained and the results of the mixed FRET pair were compared to their individual spectra. 
In general, 200 nM (final) of each protein was used, whether mixed with its FRET partner or not. 
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Chapter 5: A biomimetic mesh 
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Discussion 
The bead methodology employed in Chapter 2 has the potential to be developed into a more 
robust mesh assembly system. Already, our minimal system has shown that Spir binds the 
barbed ends of existing filaments and the pointed ends of nucleated filaments to create 
filament—vesicle bridges. Further, this system showed that CapuCT enables the construction of 
these bridges in the presence of ubiquitous ABPs like profilin and capping protein by 
processively protecting and accelerating the elongation of barbed ends of Spir-nucleated 
filaments. Spir mutants which enhanced the nucleation of Spir in pyrene assays – both alone 
and in synergy conditions with Capu – also demonstrated enhanced nucleation and synergy 
with Capu on beads. Thus, we clearly discriminated the strengths and weaknesses of the 
existing models describing Spir—Capu synergy. 
 
The addition of other interactors to this system offers more complex aspects of mesh regulation 
to be visualized in vitro. Candidates for introduction to this method are numerous. Proteins like 
Rab11 and MyoV can be directly conjugated to beads and/or complexed with SpirNT on beads, 
while smaller molecules like depolymerization agents or the Spir(490-520) peptide can be 
introduced by flow. In the former case, MyoV could be tested for interactions with SpirNT and 
regulation of SpirNT-bead activity and/or mesh contraction observed, through MyoV’s motor 
activity (i.e. Fig. 2-7C’). In the latter case, Spir’s ability to nucleate, synergize with CapuCT, or 
interact with other proteins may be modified in unique ways by the presence of a small molecule 
inhibitor, peptide, or even microtubules and crosslinkers. 
 
In addition to introducing new components, more precise interrogations of mesh assembly and 
structure are afforded by the wealth of existing Spir and Capu mutants in the Quinlan lab. In 
Chapter 3, we show that various Spir functions – including nucleation, sequestration, filament 
capture, and filament retention – can be targeted and tuned through point mutations within 
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Spir’s four WH2 domains. Furthermore, we show that Spir’s amino acids 490-520 offer an 
additional layer of regulation and predict that MyoV can serve as an activator of SpirNT when 
these residues are present. Finally, we demonstrated that the CapuCT(I706A) mutant is an 
excellent tool to further study the role(s) Capu plays in synergy. With both abolished nucleation 
and acceleration of elongation, while remaining dimeric and processive, this mutant provides 
potential insights into formin behavior writ large. Modular combinations of Spir WH2 mutants, in 
conjunction with CapuCT(I706A), offer a long list of permutations and potential for deeper, 
mechanistic insights into Spir—Capu synergy. 
 
As the bead methodology is further refined to produce a mesh more faithful to the in vivo 
structure, superior Spir/Capu localization data and structural studies of the mesh will be critical. 
We note the potential for a functional Spir—Capu FRET system in Chapter 3. A better 
understanding of when/where Spir and Capu interact in vivo (particularly, in relation to mesh 
and vesicles) would permit us to further optimize the in vitro mesh assembly system and 
visualize the more complex aspects of its behavior than could be done in vivo – i.e. single-
filament dynamics. Recent advances in super-resolution microscopy and better actin-labeling 
probes now permit the finer details and nuance of mesh to be visualized. Pairing these 
technologies with a working FRET system and a more sophisticated bead methodology would 
leave out of reach very few of the major questions remaining for Spir—Capu synergy. 
 
Several systems have been noted to contain meshes of actin which serve various, essential 
roles in cell polarity. In the fly and the mouse, direct interactions between Spir and Capu and 
their homologues crucially regulate mesh, and conserved binding residues indicate that such 
interactions are important for their roles in other species. A continued interrogation of Spir—
Capu synergy offers valuable insights into the curious complexity of actin nucleators across 
biology. 
